Nothing Special   »   [go: up one dir, main page]

Next Issue
Volume 22, January
Previous Issue
Volume 21, November
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
molecules-logo

Journal Browser

Journal Browser

Molecules, Volume 21, Issue 12 (December 2016) – 153 articles

Cover Story (view full-size image): "Microtubule targeting agents, some of the most effective drugs used in the treatment of cancer, consist of two classes: microtubule stabilizing and destabilizing compounds. We have synthesized and characterized a novel class of compounds that have properties of both microtubule stabilizing and destabilizing drugs. Distinct interactions of these compounds, modeled into the colchicine site on tubulin, suggest novel interactions that may underlie these mixed effects on microtubule structure. The dual effects of these so-called Janus compounds represent a novel phenotype that will provide insights into microtubule dynamics and structure and represent the first class of synthetically tractable small molecules that can elicit microtubule stabilization." View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
476 KiB  
Review
Preventive Effects of Catechins on Cardiovascular Disease
by Xiao-Qiang Chen, Ting Hu, Yu Han, Wei Huang, Hai-Bo Yuan, Yun-Tian Zhang, Yu Du and Yong-Wen Jiang
Molecules 2016, 21(12), 1759; https://doi.org/10.3390/molecules21121759 - 21 Dec 2016
Cited by 83 | Viewed by 8071
Abstract
Catechins are polyphenolic phytochemicals with many important physiological activities that play a multifaceted health care function in the human body, especially in the prevention of cardiovascular disease. In this paper, various experimental and clinical studies have revealed the role of catechins in the [...] Read more.
Catechins are polyphenolic phytochemicals with many important physiological activities that play a multifaceted health care function in the human body, especially in the prevention of cardiovascular disease. In this paper, various experimental and clinical studies have revealed the role of catechins in the prevention and treatment of cardiovascular disorders, and we review the preventive effects of catechins on cardiovascular disease from the following aspects: Regulating lipid metabolism, regulating blood lipid metabolism, vascular endothelial protection, and reducing blood pressure. Full article
(This article belongs to the Special Issue Catechins and Human Health: Current State of the Science)
Show Figures

Figure 1

Figure 1
<p>The structures of four kinds of catechins: epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG), and epigallocatechin gallate (EGCG) [<a href="#B25-molecules-21-01759" class="html-bibr">25</a>].</p>
Full article ">Figure 2
<p>Mechanism of EGCG auto-oxidation and dimerization.</p>
Full article ">
5641 KiB  
Article
Cryptolepine, a Plant Alkaloid, Inhibits the Growth of Non-Melanoma Skin Cancer Cells through Inhibition of Topoisomerase and Induction of DNA Damage
by Harish C. Pal and Santosh K. Katiyar
Molecules 2016, 21(12), 1758; https://doi.org/10.3390/molecules21121758 - 21 Dec 2016
Cited by 46 | Viewed by 7152
Abstract
Topoisomerases have been shown to have roles in cancer progression. Here, we have examined the effect of cryptolepine, a plant alkaloid, on the growth of human non-melanoma skin cancer cells (NMSCC) and underlying mechanism of action. For this purpose SCC-13 and A431 cell [...] Read more.
Topoisomerases have been shown to have roles in cancer progression. Here, we have examined the effect of cryptolepine, a plant alkaloid, on the growth of human non-melanoma skin cancer cells (NMSCC) and underlying mechanism of action. For this purpose SCC-13 and A431 cell lines were used as an in vitro model. Our study reveals that SCC-13 and A431 cells express higher levels as well as activity of topoisomerase (Topo I and Topo II) compared with normal human epidermal keratinocytes. Treatment of NMSCC with cryptolepine (2.5, 5.0 and 7.5 µM) for 24 h resulted in marked decrease in topoisomerase activity, which was associated with substantial DNA damage as detected by the comet assay. Cryptolepine induced DNA damage resulted in: (i) an increase in the phosphorylation of ATM/ATR, BRCA1, Chk1/Chk2 and γH2AX; (ii) activation of p53 signaling cascade, including enhanced protein expressions of p16 and p21; (iii) downregulation of cyclin-dependent kinases, cyclin D1, cyclin A, cyclin E and proteins involved in cell division (e.g., Cdc25a and Cdc25b) leading to cell cycle arrest at S-phase; and (iv) mitochondrial membrane potential was disrupted and cytochrome c released. These changes in NMSCC by cryptolepine resulted in significant reduction in cell viability, colony formation and increase in apoptotic cell death. Full article
(This article belongs to the Special Issue Cancer Chemoprevention)
Show Figures

Figure 1

Figure 1
<p>Comparison of basal expression and activity of topoisomerases in non-melanoma skin cancer (NMSC) cell lines, and effect of cryptolepine on topoisomerase in NMSC cells. (<b>A</b>) Molecular structure of cryptolepine, a plant alkaloid; (<b>B</b>) Basal expression of topoisomerases (Topo I and Topo IIα) in various cell lines was determined in total cell lysates using western blot analysis; (<b>C</b>) Topoisomerases containing cell extracts were subjected to the analysis of enzyme activity using topoisomerase activity assay kit, as detailed in Materials and Methods; (<b>D</b>) SCC-13 and A431 cells were treated with various concentrations of cryptolepine (0, 2.5, 5.0, and 7.5 μM) for 24 h, total cell lysates were subjected to western blot analysis for the detection of Topo I and Topo IIα. The numerical value of band density is shown under blot, and the band density of control was arbitrarily selected as 1 and comparison was then made with densitometry values of other treatment groups; (<b>E</b>) Cell extracts containing topoisomerases from different treatment groups were subjected to the analysis of enzyme activity using topoisomerase activity assay kit. Topo = topoisomerase, Sup DNA = Supercoiled DNA, Rel DNA = Relax DNA.</p>
Full article ">Figure 2
<p>Treatment of NMSC cells with cryptolepine induces DNA damage which is associated with inhibition of topoisomerase IIα expression and induction of DNA-PK protein expression. (<b>A</b>) Cryptolepine (0, 2.5, 5.0 and 7.5 µM for 24 h) induced DNA damage was determined by comet assay, as described in Materials and Methods; (<b>B</b>) Comet’s tail length was measured using opencomet software. Data are expressed in terms of tail length as mean ± SD, <span class="html-italic">n</span> = 6. Statistical significance versus control, * <span class="html-italic">p</span> &lt; 0.05; <sup>¶</sup> <span class="html-italic">p</span> &lt; 0.01; <sup>†</sup> <span class="html-italic">p</span> &lt; 0.001; (<b>C</b>) Approximately 5 × 10<sup>4</sup> SCC-13 or A431 cells/well of four chambered slide were treated with 0, 2.5, 5.0 and 7.5 µM of cryptolepine for 24 h and stained with topoisomerase IIα- and DNA-PK-specific primary antibodies for double staining, as detailed in Materials and methods. After washing with PBS, slides were mounted with vectashield mounting media containing DAPI. Representative photomicrographs are shown. Bar size = 5 µm.</p>
Full article ">Figure 3
<p>Treatment of cryptolepine enhances the expressions of DNA damage response mediators and effector cascade in NMSC cells. (<b>A</b>) Cryptolepine treatment enhances expressions of DNA damage response proteins in SCC-13 and A431 cells; and (<b>B</b>) DNA damage effectors in SCC-13 and A431 cells. Cells were treated with cryptolepine (0, 2.5, 5.0 and 7.5 µM) for 24 h. Cell lysates were subjected to western blot analysis for determination of the levels of different protein biomarkers. Blots were developed with chemiluminescence-specific ECL. The numerical value of band density is shown under blot, and the band density of control was arbitrarily selected as 1 and comparison was then made with densitometry values of other treatment groups, as detailed under Materials and Methods. Equal loading of proteins was confirmed by stripping the membranes and probed with β-actin or vinculin.</p>
Full article ">Figure 4
<p>Treatment of cryptolepine induces S-phase cell cycle arrest in NMSC cells. (<b>A</b>) Approximately 2 × 10<sup>5</sup> SCC-13 or A431 cells were treated with different doses of cryptolepine (0, 2.5, 5.0 and 7.5 µM) for 24 h. After harvesting the cells, cells were stained with propidium iodide and analyzed on Accuri Q6 flow cytometer for DNA content in different phases of cell cycle. M3 compartment shows the cells in S-phase; (<b>B</b>) Cell lysates from cryptolepine treated and non-treated controls of SCC-13 and A431 cells were subjected to western blot analysis to determine the effect on expression of cell cycle regulatory proteins. The numerical value of band density is shown under blot, and the band density of control (non-treated group) was arbitrarily selected as 1 and comparison was then made with densitometry values of other treatment groups.</p>
Full article ">Figure 5
<p>Cryptolepine treatment stimulates the loss of mitochondrial membrane potential and subsequently release cytochrome c in NMSC cells. (<b>A</b>) SCC-13 or A431 cells were treated with various concentrations of cryptolepine (0, 2.5, 5.0 and 7.5 µM) for 24 h, then double staining was performed using phospho-p53- and cytochrome c specific primary antibodies following the immunohistochemistry protocol as detailed under Materials and Methods. Green color reflects the release of cytochrome c, red color shows the expression of P-p53 and DAPI shows blue. Representative photomicrographs are shown. Bar size = 5 µm; (<b>B</b>) SCC-13 or A431 cells were treated with different doses of cryptolepine (0, 2.5, 5.0 and 7.5 µM) for 24 h. Cells were incubated with rhodamine-123 for 30 min and then harvested for the analysis of mitochondrial membrane potential using Accuri Q6 flow cytometer. M1 compartment indicates percent of cells with intact mitochondrial membrane potential while M2 compartment indicates percent cells with loss of mitochondrial membrane potential.</p>
Full article ">Figure 6
<p>Treatment of cryptolepine inhibits cell viability, induces apoptosis and reduced colony formation capacity of NMSC cells. NMSC cells (SCC-13 and A431) and NHEK were treated with different concentrations of cryptolepine (0, 2.5, 5.0 and 7.5 µM) for 24 and 48 h. (<b>A</b>) Cell viability was determined using MTT assay. Experiment was performed in six individual wells of 96 wells plate and cell viability was compared with the control, <span class="html-italic">n</span> = 6. Statistical significance versus control, * <span class="html-italic">p</span> &lt; 0.05; <sup>¶</sup> <span class="html-italic">p</span> &lt; 0.01; <sup>†</sup> <span class="html-italic">p</span> &lt; 0.001; (<b>B</b>) Cells were treated with various concentrations of cryptolepine (0, 2.5, 5.0 and 7.5 µM) for 24 h. Thereafter, cells were harvested, and incubated with Alexa488 reagents and PI for 30 min, percent apoptotic cell population was analyzed using Accuri Q6 flow cytometer, as described in Materials and Methods; (<b>C</b>) After treatment with cryptolepine (0, 2.5 and 5.0 µM) for 24 h, 500 NMSC cells were allowed to grow in 6-well plates in duplicate for 2 weeks at 37 °C in an incubator. After two weeks, colonies were identified using 0.5% crystal violet. Cell colonies were scanned for photographs, and are seen in blue; (<b>D</b>) Western blot analysis indicates that the levels of Topo IIα was markedly decreased in the NMSC cells after knocked-down of Topo IIα using siRNA kit; (<b>E</b>) Cell viability in SCC-13 and A431 cell lines was significantly decreased (<span class="html-italic">p</span> &lt; 0.001) after knock-down of Topo IIα using siRNA kit compared to the cells treated with control siRNA.</p>
Full article ">Figure 7
<p>Schematic representation of cryptolepine-induced effects on non-melanoma skin cancer cells (NMSCC). Cryptolepine inhibits topoisomerase and causes DNA damage in skin cancer cells. Cryptolepine induced DNA damage response leads to activation of ATM/ATR and checkpoint kinases (Chk1/Chk2) resulting in activation of p53 signaling and modulation of cell cycle regulatory proteins. Together, these changes induced by cryptolepine results in cell cycle arrest and ultimately induction of apoptotic cell death of NMSCC.</p>
Full article ">
1500 KiB  
Article
Pharmacological Properties of Riparin IV in Models of Pain and Inflammation
by Olívia Azevêdo Nascimento, Renan Fernandes do Espírito-Santo, Luíza Carolina França Opretzka, José Maria Barbosa-Filho, Stanley Juan Chavez Gutierrez, Cristiane Flora Villarreal and Milena Botelho Pereira Soares
Molecules 2016, 21(12), 1757; https://doi.org/10.3390/molecules21121757 - 21 Dec 2016
Cited by 20 | Viewed by 5539
Abstract
Riparins, natural alkaloids of the alkamide group, can be synthesized by simple methods, enhancing their potential application in pharmaceutical development. Here, the pharmacological properties of riparins were investigated in in vitro and in vivo assays of pain and inflammation in Swiss mice. Inflammatory [...] Read more.
Riparins, natural alkaloids of the alkamide group, can be synthesized by simple methods, enhancing their potential application in pharmaceutical development. Here, the pharmacological properties of riparins were investigated in in vitro and in vivo assays of pain and inflammation in Swiss mice. Inflammatory mediators were measured by radioimmunoassay and Real-Time PCR. Riparins I, II, III and IV (1.56–100 mg/kg; ip) produced dose-related antinociceptive effects in the formalin test, exhibiting ED50 values of 22.93, 114.2, 31.05 and 6.63 mg/kg, respectively. Taking the greater potency as steering parameter, riparin IV was further investigated. Riparin IV did not produce antinociceptive effect on the tail flick, suggesting that its antinociception is not a centrally-mediated action. In fact, riparin IV (1.56–25 mg/kg) produced dose-related antinociceptive and antiedematogenic effects on the complete Freund’s adjuvant (CFA)-induced paw inflammation in mice. During CFA-induced inflammation, riparin IV did not modulate either the production of cytokines, TNF-α and IL-10, or COX-2 mRNA expression. On the other hand, riparin IV decreased the PGE2 levels in the inflamed paw. In in vitro assays, riparin IV did not exhibit suppressive activities in activated macrophages. These results indicate, for the first time, that riparin IV induces antinociceptive and anti-inflammatory effects, possibly through the inhibition of prostanoid production. Full article
(This article belongs to the Special Issue Natural Product: A Continuing Source of Novel Drug Leads)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structure of riparins I, II, III and IV.</p>
Full article ">Figure 2
<p>Antinociceptive effects of riparins I, II, III and IV on formalin test. Panels (<b>A</b>,<b>C</b>,<b>E</b>,<b>G</b>) represent the effects of riparins I–IV, respectively, on the early phase of formalin-induced nociception in mice. Panels (<b>B</b>,<b>D</b>,<b>F</b>,<b>H</b>) represent the effects of riparins on the late phase of formalin test. ED<sub>50</sub> values for riparins were calculated using the percent of nociception reversion at late phase of the formalin test. For the dose-response analysis, the effects of increasing doses of riparins (1.56 to 100 mg/kg) were tested. Mice were treated with riparins I–IV or vehicle (Veh; Tween 80 5%; control group) by intraperitoneal route 40 min before formalin (injected at time zero). Indomethacin (In; 5 mg/kg) and morphine (Mor; 5 mg/kg) were used as reference drugs. All data are reported as means ± SEM; <span class="html-italic">n</span> = 6 mice per group. * Significantly different from control group (<span class="html-italic">p</span> &lt; 0.05); ** Significantly different from control group (<span class="html-italic">p</span> &lt; 0.01); *** significantly different from control group (<span class="html-italic">p</span> &lt; 0.001) as determined by ANOVA followed by Tukey’s test.</p>
Full article ">Figure 3
<p>Effects of riparins on rota-rod and tail flick tests in mice. Panel (<b>A</b>) shows the effects of riparins I, II, III and IV (100 mg/kg) on motor function in mice. Bar graphs representing the run time on the rota-rod, 40 min after the intraperitoneal administration of riparins I–IV (100 mg/kg), vehicle (Veh; Tween 80 5%; control group) or diazepam (DZP; 10 mg/kg, reference drug); Panel (<b>B</b>) shows tail flick test data represented as Antinociception Index. The thermal nociceptive threshold was evaluated before (B) and up to 120 min following intraperitoneal administration of riparin IV (25 mg/kg), vehicle (Veh: Tween 80.5%; control group) or morphine (Mor: 5 mg/kg; reference drug). All data are reported as means ± SEM; <span class="html-italic">n</span> = 6 mice per group. *** Significantly different from control group (<span class="html-italic">p</span> &lt; 0.001) as determined by ANOVA followed by Tukey’s test (Panel A) or Two-way ANOVA followed by Bonferroni’s test (B).</p>
Full article ">Figure 4
<p>Anti-inflammatory effects of riparin IV on complete Freund’s adjuvant (CFA)-induced paw inflammation. Mice were treated with riparin IV (1.56–25 mg/kg), dexamethasone (Dexa; 2 mg/kg; reference drug), or vehicle (Veh: Tween 80 5%; control group) by ip route 40 min before the intraplantar injection of CFA (20 μL/paw). (<b>A</b>) Inflammatory hyperalgesia measured at 2, 4, 8 and 24 h after the CFA stimulus. B (basal) represents the average threshold of the animals before surgery. The mechanical nociceptive threshold (axis of ordinates) is represented as the filament weight (g) at which the animal responds in 50% of presentations; (<b>B</b>) Paw edema measured at 2, 4, 8 and 24 h after the CFA injection, represented as variation of paw volume in mm<sup>3</sup>. Data are expressed as means ± SEM; <span class="html-italic">n</span> = 6 mice per group. * Significantly different from the control group (p &lt; 0.05); ** Significantly different from the control group (<span class="html-italic">p</span> &lt; 0.01); *** Significantly different from the control group (<span class="html-italic">p</span> &lt; 0.001). Two-way ANOVA followed by Bonferroni’s test.</p>
Full article ">Figure 5
<p>Effects of riparin IV on paw inflammatory mediators levels during CFA-induced inflammation. Mice were treated ip with riparin IV (6.25 mg/kg), dexamethasone (Dexa; 2 mg/kg; reference drug), or vehicle (Veh: Tween 80 5%; control group) 40 min before the intraplantar injection of CFA (20 μL/paw). The naïve group consists of mice that did not receive any experimental manipulation. Panels show the paw levels of (<b>A</b>) tumor necrosis factor-α (TNF-α), (<b>B</b>)interleukin-10 (IL-10) or (<b>C</b>) prostaglandin E<sub>2</sub> (PGE<sub>2</sub>), determined in skin tissues samples 3 h after the CFA injection. The results are expressed as picograms of cytokine per milligram of protein. Panel D shows the paw levels of COX-2 mRNA measured by qRT-PCR 3 h after the CFA injection. All data are reported as means ± SEM; <span class="html-italic">n</span> = 6 mice per group. * Significantly different from control group (<span class="html-italic">p</span> &lt; 0.05); ** Significantly different from control group (<span class="html-italic">p</span> &lt; 0.01); *** Significantly different from control group (<span class="html-italic">p</span> &lt; 0.001); <sup>#</sup> Significantly different from the naive group (<span class="html-italic">p</span> &lt; 0.05) as determined by ANOVA followed by Tukey’s test.</p>
Full article ">Figure 6
<p>Effect of riparin IV on nitric oxide production in J774 macrophages. Concentrations of nitrite were determined in J774 macrophages treated with vehicle (Tween 80 5%, Ct, control group), riparin IV (6.2–50 μM) or dexamethasone (Dexa; 40 µM) in the presence of LPS (500 ng/mL) + IFN-γ (5 ng/mL). Cell-free supernatants were collected for nitrite quantification by the Griess method. Values represent the means ± SEM of three determinations obtained in one of three experiments performed. *** Significantly different from the vehicle treated cultures (<span class="html-italic">p</span> &lt; 0.001). ANOVA followed by Tukey´s multiple comparison test.</p>
Full article ">Figure 7
<p>Effect of riparin IV on cytokine production by activated J774 macrophages. Concentrations of TNF-α (<b>A</b>), IL-6 (<b>B</b>) and IL-10 (<b>C</b>) were determined in cultures of J774 macrophages treated with vehicle (Tween 80 5%, Ct, control group), riparin IV (6.2–50 μM) or dexamethasone (Dexa; 40 µM) in the presence of LPS (500 ng/mL) plus IFN-γ (5 ng/mL). Cell-free supernatants were collected for cytokines measurement by ELISA. Values represent the means ± SEM of four determinations obtained in one of three experiments performed. * Significantly different from the vehicle treated cultures stimulated with LPS + IFN-γ (<span class="html-italic">p</span> &lt; 0.05). ** <span class="html-italic">p</span> &lt; 0.05. ANOVA followed by Tukey’s multiple comparison test.</p>
Full article ">
7885 KiB  
Article
Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway
by Jianming Wu, Xiao Ke, Wei Fu, Xiaoping Gao, Hongcheng Zhang, Wei Wang, Na Ma, Manxi Zhao, Xiaofeng Hao and Zhirong Zhang
Molecules 2016, 21(12), 1756; https://doi.org/10.3390/molecules21121756 - 21 Dec 2016
Cited by 42 | Viewed by 7654
Abstract
Specnuezhenide (SPN), one of the main ingredients of Chinese medicine “Nü-zhen-zi”, has anti-angiogenic and vision improvement effects. However, studies of its effect on retinal neovascularization are limited so far. In the present study, we established a vascular endothelial growth factor A (VEGFA) secretion [...] Read more.
Specnuezhenide (SPN), one of the main ingredients of Chinese medicine “Nü-zhen-zi”, has anti-angiogenic and vision improvement effects. However, studies of its effect on retinal neovascularization are limited so far. In the present study, we established a vascular endothelial growth factor A (VEGFA) secretion model of human acute retinal pigment epithelial-19 (ARPE-19) cells by exposure of 150 μM CoCl2 to the cells and determined the VEGFA concentrations, the mRNA expressions of VEGFA, hypoxia inducible factor-1α (HIF-1α) & prolyl hydroxylases 2 (PHD-2), and the protein expressions of HIF-1α and PHD-2 after treatment of 3-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole (YC-1, 1.0 μg/mL) or SPN (0.2, 1.0 and 5.0 μg/mL). Furthermore, rat pups with retinopathy were treated with SPN (5.0 and 10.0 mg/kg) in an 80% oxygen atmosphere and the retinal avascular areas were assessed through visualization using infusion of ADPase and H&E stains. The results showed that SPN inhibited VEGFA secretion by ARPE-19 cells under hypoxia condition, down-regulated the mRNA expressions of VEGFA and PHD-2 slightly, and the protein expressions of VEGFA, HIF-1α and PHD-2 significantly in vitro. SPN also prevented hypoxia-induced retinal neovascularization in a rat model of oxygen-induced retinopathy in vivo. These results indicate that SPN ameliorates retinal neovascularization through inhibition of HIF-1α/VEGF signaling pathway. Therefore, SPN has the potential to be developed as an agent for the prevention and treatment of diabetic retinopathy. Full article
(This article belongs to the Special Issue Natural Product: A Continuing Source of Novel Drug Leads)
Show Figures

Figure 1

Figure 1
<p>Structure of methyl (5<span class="html-italic">E</span>,6<span class="html-italic">S</span>)-5-ethylidene-4-[2-oxo-2-[[(2<span class="html-italic">R</span>,3<span class="html-italic">S</span>,4<span class="html-italic">S</span>,5<span class="html-italic">R</span>,6<span class="html-italic">R</span>)-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl]methoxy]ethyl]-6-[(2<span class="html-italic">S</span>,3<span class="html-italic">R</span>,4<span class="html-italic">S</span>,5<span class="html-italic">S</span>,6<span class="html-italic">R</span>)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4<span class="html-italic">H</span>-pyran-3-carboxylate (specnuezhenide, SPN).</p>
Full article ">Figure 2
<p>Effect of SPN on VEGFA secretion in ARPE-19 cells at 48 h of hypoxic condition. The results are representative of at least three independent experiments run in triplicate and expressed as the mean ± SD (<span class="html-italic">n</span> = 9). ** <span class="html-italic">p</span> &lt; 0.01 vs. vehicle plus CoCl<sub>2</sub>-treated group. The control cells were treated with vehicle (culture medium containing 0.1% DMSO).</p>
Full article ">Figure 3
<p>Effects of SPN on the mRNA expressions of VEGFA, HIF-1α and PHD-2 in ARPE-19 cells at 24 h of normoxia or hypoxic conditions. (<b>a</b>): VEGFA mRNA expression; (<b>b</b>): HIF-1α mRNA expression; (<b>c</b>): PHD-2 mRNA expression. The results are representative of at least three independent experiments run in triplicate and expressed as the mean ± SD (<span class="html-italic">n</span> = 9). * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. vehicle plus CoCl<sub>2</sub>-treated group. The control cells were treated with vehicle (culture medium containing 0.1% DMSO).</p>
Full article ">Figure 4
<p>Effects of SPN on the protein expressions of HIF-1α and PHD-2 in ARPE-19 cells at 24 h of normoxia or hypoxic conditions. (<b>a</b>): HIF-1α protein expression; (<b>b</b>): PHD-2 protein expression. The results are representative of at least three independent experiments run in triplicate and expressed as the mean ± SD (<span class="html-italic">n</span> = 9). ** <span class="html-italic">p</span> &lt; 0.01 vs. vehicle plus CoCl<sub>2</sub>-treated group. The control cells were treated with vehicle (culture medium containing 0.1% DMSO). Beta-actin was used as the loading control.</p>
Full article ">Figure 5
<p>Effects of SPN and Conbercept (CBC) on quantification of retinal neovascular area ration in the rat model of oxygen-induced retinopathy (OIR). (<b>a</b>): Retinal neovascular area ration. (<b>b</b>): Inhibition of retinal neovascular area. The results were expressed as means ± SD (<span class="html-italic">n</span> = 10). ** <span class="html-italic">p</span> &lt; 0.01, compared with vehicle plus 80% oxygen group.</p>
Full article ">Figure 6
<p>The in vivo effect of SPN and Conbercept on retinopathy of rats in ADPase-stained retinal sections (40×). Central retinal region of rat pups fostered under normoxia conditions (<b>a1</b>); OIR rats intraperitoneally administered with NS (<b>b1</b>), 1.0 mg/kg Conbercept (<b>c1</b>), 5.0 mg/kg SPN (<b>d1</b>) or 10.0 mg/kg SPN (<b>e1</b>). Peripheral retinal region of control, rat pups fostered under normoxia conditions (<b>a2</b>); OIR rats intraperitoneally administered with NS (<b>b2</b>), 1.0 mg/kg Conbercept (<b>c2</b>), 5.0 mg/kg SPN (<b>d2</b>) or 10.0 mg/kg SPN (<b>e2</b>). Ten rats were used for each group (<span class="html-italic">n</span> = 10).</p>
Full article ">Figure 6 Cont.
<p>The in vivo effect of SPN and Conbercept on retinopathy of rats in ADPase-stained retinal sections (40×). Central retinal region of rat pups fostered under normoxia conditions (<b>a1</b>); OIR rats intraperitoneally administered with NS (<b>b1</b>), 1.0 mg/kg Conbercept (<b>c1</b>), 5.0 mg/kg SPN (<b>d1</b>) or 10.0 mg/kg SPN (<b>e1</b>). Peripheral retinal region of control, rat pups fostered under normoxia conditions (<b>a2</b>); OIR rats intraperitoneally administered with NS (<b>b2</b>), 1.0 mg/kg Conbercept (<b>c2</b>), 5.0 mg/kg SPN (<b>d2</b>) or 10.0 mg/kg SPN (<b>e2</b>). Ten rats were used for each group (<span class="html-italic">n</span> = 10).</p>
Full article ">Figure 7
<p>The in vivo effect of SPN on retinal neovascularization in H&amp;E-stained retinal tissue sections (400×). Control group (<b>a</b>), rat pups fostered under normoxia condition; oxygen-induced retinopathy (OIR) rats were intraperitoneally administered with normal saline (negative control, <b>b</b>), 1.0 mg/kg Conbercept (positive control, <b>c</b>), or 10.0 mg/kg SPN (<b>d</b>). The arrows show neovascular nuclei or vessels. Ten rats were used for each group.</p>
Full article ">Figure 8
<p>Effect of SPN on hypoxia-induced retinal angiogenesis.</p>
Full article ">
1013 KiB  
Article
Polyphenol Composition, Antioxidant Activity and Cytotoxicity of Seeds from Two Underexploited Wild Licania Species: L. rigida and L. tomentosa
by Igor Parra Pessoa, José Joaquim Lopes Neto, Thiago Silva de Almeida, Davi Felipe Farias, Leonardo Rogério Vieira, Jackeline Lima de Medeiros, Aline Augusti Boligon, Ad Peijnenburg, Ivan Castelar and Ana Fontenele Urano Carvalho
Molecules 2016, 21(12), 1755; https://doi.org/10.3390/molecules21121755 - 21 Dec 2016
Cited by 15 | Viewed by 6997
Abstract
Studies have shown the benefit of antioxidants in the prevention or treatment of human diseases and promoted a growing interest in new sources of plant antioxidants for pharmacological use. This study aimed to add value to two underexploited wild plant species (Licania [...] Read more.
Studies have shown the benefit of antioxidants in the prevention or treatment of human diseases and promoted a growing interest in new sources of plant antioxidants for pharmacological use. This study aimed to add value to two underexploited wild plant species (Licania rigida) and L. tomentosa) from Brazilian flora. Thus, the phenolic compounds profile of their seed ethanol extract and derived fractions were elucidated by HPLC, the antioxidant capacity was assessed by in vitro chemical tests and the cytotoxicity determined using the human carcinoma cell lines MCF-7 and Caco-2. Eleven phenolic compounds were identified in the extracts of each species. The extracts and fractions showed excellent antioxidant activity in the DPPH assay (SC50, ranging from 9.15 to 248.8 µg/mL). The aqueous fraction of L. rigida seeds was most effective in preventing lipid peroxidation under basal conditions (IC50 60.80 µg/mL) whereas, in the presence of stress inducer, the methanolic fraction of L. tomentosa performed best (IC50 8.55 µg/mL). None of the samples showed iron chelating capacity. Ethanolic seed extracts of both species did not reveal any cytotoxicity against MCF-7 and Caco-2 cells. Both plant species showed a promising phenolic profile with potent antioxidant capacity and deserve attention to be sustainably explored. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>High performance liquid chromatography phenolics and flavonoids profile of <span class="html-italic">L. tomentosa</span> ethanolic extract (<b>a</b>) and <span class="html-italic">L. rigida</span> ethanolic extract (<b>b</b>). Gallic acid (peak 1), catechin (peak 2), chlorogenic acid (peak 3), caffeic acid (peak 4), epicatechin (peak 5), ellagic acid (peak 6), rutin (peak 7), quercitrin (peak 8), quercetin (peak 9), kaempferol (peak 10) and kaempferol glycoside (peak 11).</p>
Full article ">Figure 2
<p>Iron chelating activity of <span class="html-italic">Licania rigida</span> (<b>a</b>) and <span class="html-italic">L. tomentosa</span> (<b>b</b>) seeds ethanolic extract and their fractions based on <span class="html-italic">o</span>-phenantroline method. Absorbance was recorded at 510 nm and percent complexation was calculated with respect to control (determined in the absence of samples and EDTA). LrEE = <span class="html-italic">L. rigida</span> ethanolic extract; LrMF = <span class="html-italic">L. rigida</span> methanolic fraction; LrEAF = <span class="html-italic">L. rigida</span> ethyl acetate fraction; LrAF = <span class="html-italic">L. rigida</span> aqueous fraction LtEE = <span class="html-italic">L. tomentosa</span> ethanolic extract; LtMF = <span class="html-italic">L. tomentosa</span> methanolic fraction; LtEAF = <span class="html-italic">L. tomentosa</span> ethyl acetate fraction; LtAF = <span class="html-italic">L. tomentosa</span> aqueous fraction; LtCF = <span class="html-italic">L. tomentosa</span> chloroform fraction; EDTA = Ethylenediamine tetraacetic acid. * Significant difference between EDTA control and all the samples in A and B (<span class="html-italic">p</span> &lt; 0.05). ** Significant difference between LtMF/LtAF and other samples in B (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Cell viability of the human breast adenocarcinoma cell line MCF-7 upon 24 h exposure to ethanolic seeds extracts of <span class="html-italic">Licania tomentosa</span> (<b>A</b>); <span class="html-italic">L. rigida</span> (<b>B</b>); quercetin (<b>C</b>) and gallic acid (<b>D</b>). DMSO, dimethyl sulfoxide; DMEM: Dulbecco's Modified Eagle's Medium; LrEE: <span class="html-italic">L. rigida</span> ethanolic extract; LtEE: <span class="html-italic">L. tomentosa</span> ethanolic extract.</p>
Full article ">Figure 4
<p>Cell viability of the human colon adenocarcinoma cell line Caco-2 upon 24 h exposure to ethanolic seeds extracts of <span class="html-italic">Licania rigida</span> (<b>A</b>); <span class="html-italic">L. tomentosa</span> (<b>B</b>); quercetin (<b>C</b>) and gallic acid (<b>D</b>). DMSO, dimethyl sulfoxide; DMEM, Dulbecco's Modified Eagle's Medium; LrEE, <span class="html-italic">L. rigida</span> ethanolic extract; LtEE, <span class="html-italic">L. tomentosa</span> ethanolic extract.</p>
Full article ">
1648 KiB  
Article
Chemical Fingerprint Analysis and Quantitative Analysis of Rosa rugosa by UPLC-DAD
by Sanawar Mansur, Rahima Abdulla, Amatjan Ayupbec and Haji Akbar Aisa
Molecules 2016, 21(12), 1754; https://doi.org/10.3390/molecules21121754 - 21 Dec 2016
Cited by 13 | Viewed by 6543
Abstract
A method based on ultra performance liquid chromatography with a diode array detector (UPLC-DAD) was developed for quantitative analysis of five active compounds and chemical fingerprint analysis of Rosa rugosa. Ten batches of R. rugosa collected from different plantations in the Xinjiang [...] Read more.
A method based on ultra performance liquid chromatography with a diode array detector (UPLC-DAD) was developed for quantitative analysis of five active compounds and chemical fingerprint analysis of Rosa rugosa. Ten batches of R. rugosa collected from different plantations in the Xinjiang region of China were used to establish the fingerprint. The feasibility and advantages of the used UPLC fingerprint were verified for its similarity evaluation by systematically comparing chromatograms with professional analytical software recommended by State Food and Drug Administration (SFDA) of China. In quantitative analysis, the five compounds showed good regression (R2 = 0.9995) within the test ranges, and the recovery of the method was in the range of 94.2%–103.8%. The similarities of liquid chromatography fingerprints of 10 batches of R. rugosa were more than 0.981. The developed UPLC fingerprint method is simple, reliable, and validated for the quality control and identification of R. rugosa. Additionally, simultaneous quantification of five major bioactive ingredients in the R. rugosa samples was conducted to interpret the consistency of the quality test. The results indicated that the UPLC fingerprint, as a characteristic distinguishing method combining similarity evaluation and quantification analysis, can be successfully used to assess the quality and to identify the authenticity of R. rugosa. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>The chemical structures of the investigated compounds.</p>
Full article ">Figure 2
<p>The typical UPLC chromatographic profile of five standards peaks: <b>1</b>: GA (3.8 3min); <b>2</b>: EA (30.7 min); <b>3</b>: kaempferol-3-<span class="html-italic">O</span>-sophoroside (38.9 min); <b>4</b>: hyperoside (48.9 min); <b>5</b>: astragalin (57.2 min).</p>
Full article ">Figure 3
<p>UPLC chromatographic fingerprints of 10 <span class="html-italic">R. rugosa</span> samples.</p>
Full article ">Figure 4
<p>The reference fingerprint of <span class="html-italic">R. rugosa</span>: (1) GA (3.783 min); (5) 2-phenylethyl-<span class="html-italic">O</span>-β-<span class="html-small-caps">d</span>-glucopyranoside (26.9 min); (6) quercetin-3-O-(2′′-<span class="html-italic">O</span>-β-<span class="html-small-caps">d</span>-glucopyranosyl)-β-<span class="html-small-caps">d</span>-glucopyranoside) (28.0 min); (7) juglanin (28.9 min) (8) EC (30.7 min); (9) avicularin (36.0 min); (10) quercetin (38.3 min); (11) kaempferol-3<span class="html-italic">-O</span>-sophoroside (38.9 min) (16) hyperoside (48.9 min); (18) astragalin (57.3 min).</p>
Full article ">
1618 KiB  
Review
Sulfur Atom in its Bound State Is a Unique Element Involved in Physiological Functions in Mammals
by Shin Koike and Yuki Ogasawara
Molecules 2016, 21(12), 1753; https://doi.org/10.3390/molecules21121753 - 21 Dec 2016
Cited by 31 | Viewed by 8208
Abstract
It was in the 1950s that the term polysulfide or persulfide was introduced in biological studies. The unfamiliar term “sulfane sulfur” sometimes appeared in papers published in the 1970s, and was defined in the review article by Westley in 1983. In the article, [...] Read more.
It was in the 1950s that the term polysulfide or persulfide was introduced in biological studies. The unfamiliar term “sulfane sulfur” sometimes appeared in papers published in the 1970s, and was defined in the review article by Westley in 1983. In the article, sulfane sulfur is described as sulfur atoms that are covalently bound only with sulfur atoms, and as this explanation was somewhat difficult to comprehend, it was not generally accepted. Thus, in the early 1990s, we redefined these sulfur species as “bound sulfur”, which easily converts to hydrogen sulfide on reduction with a thiol reducing agent. In other words, bound sulfur refers to a sulfur atom that exists in a zero to divalent form (0 to −2). The first part of this review focuses on the fluorescent derivatization HPLC method—which we developed for measurement of bound sulfur—and explains the distribution of bound sulfur and the hydrogen sulfide-producing ability of various tissues, as clarified by this method. Next, we discuss diverse physiological functions and involvement of polysulfide, a typical type of bound sulfur, in the redox regulation system. Additionally, we also address its possible physiological role in the central nervous system, based on its action of scavenging reactive carbonyl compounds. Full article
(This article belongs to the Special Issue Sulfur Atom: Element for Adaptation to an Oxidative Environment 2016)
Show Figures

Figure 1

Figure 1
<p>Definition of sulfane sulfur and bound sulfur. * sulfane sulfur.</p>
Full article ">Figure 2
<p>H<sub>2</sub>S and bound sulfur generation from <span class="html-small-caps">l</span>-cysteine (<b>A</b>) and <span class="html-small-caps">d</span>-cysteine (<b>B</b>) in mammalian tissues. CBS: cystathionine β-synthase; CSE: cystathionine γ-lyase, CAT: cysteine aminotransferase, MST: mercaptopyruvate sulfurtransferase, α-KG: α-ketoglutarate, DAO: <span class="html-small-caps">d</span>-amino acid oxidase, 3MP: 3-mercaptopyruvate, red: reduction; oxi: oxidation.</p>
Full article ">Figure 3
<p>Bound sulfur activates the nuclear factor erythroid related factor 2 (Nrf2) system through a structural change of Kelch-like ECH-associated protein 1 (Keap1) and promotion of the AKT/phosphoinositide 3-kinase (PI3K) signaling pathway. ARE: antioxidant response element; GSH: glutathione; HO-1: heme oxygenase 1.</p>
Full article ">Figure 4
<p>Proposed mechanisms of the protective effects of polysulfides against carbonyl stress in neuronal cells. MG: methylglyoxal; GLO: glyoxalase; AGE: advanced glycation end product, CNS: central nervous system.</p>
Full article ">
151 KiB  
Editorial
Recent Advances in Olefin Metathesis
by Georgios C. Vougioukalakis
Molecules 2016, 21(12), 1751; https://doi.org/10.3390/molecules21121751 - 21 Dec 2016
Cited by 2 | Viewed by 4523
Abstract
Olefin metathesis is one of the most significant developments of the last 20 years in the fields of organic chemistry, polymers synthesis, and materials science [1–7]. [...]
Full article
(This article belongs to the Special Issue Olefin Metathesis)
1331 KiB  
Article
New Iridoid Glucosides from Caryopteris incana (Thunb.) Miq. and Their α-Glucosidase Inhibitory Activities
by Xu-Dong Mao, Gui-Xin Chou, Sen-Miao Zhao and Cheng-Gang Zhang
Molecules 2016, 21(12), 1749; https://doi.org/10.3390/molecules21121749 - 21 Dec 2016
Cited by 8 | Viewed by 5163
Abstract
In our continued investigations of the plant Caryopteris incana, five new iridoid glucosides 15, including two cis-trans-isomers, 3 and 4, along with six known compounds 611, were isolated from the n-butyl alcohol ( [...] Read more.
In our continued investigations of the plant Caryopteris incana, five new iridoid glucosides 15, including two cis-trans-isomers, 3 and 4, along with six known compounds 611, were isolated from the n-butyl alcohol (n-BuOH) soluble fraction of whole dried material of Caryopteris incana. Their structures were established by a combination of spectroscopic techniques, including 1D and 2D NMR and high resolution electrospray ionization mass spectroscopy (HR-ESI-MS). Furthermore, all isolates were evaluated for their yeast α-glucosidase inhibitory effects. Among these compounds, 48 and 10 exhibited potent inhibition of α-glucosidase. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structures of compounds <b>1</b>–<b>5</b>.</p>
Full article ">Figure 2
<p>Selected heteronuclear multiple bond correlations (HMBC) for compound <b>1</b>.</p>
Full article ">Figure 3
<p>Selected Nuclear Overhauser Effect Spectroscopy (NOESY) correlations for compound <b>1</b>.</p>
Full article ">Figure 4
<p>Selected HMBC correlations for compound <b>5</b>.</p>
Full article ">Figure 5
<p>Selected NOESY correlations for compound <b>5</b>.</p>
Full article ">Figure 6
<p>Chemical structures of isolated compounds <b>6</b>–<b>11</b>.</p>
Full article ">
2661 KiB  
Article
Hypervalent Iodine(III)-Induced Domino Oxidative Cyclization for the Synthesis of Cyclopenta[b]furans
by Mei-Huey Lin, Yu-Chun Chen, Shih-Hao Chiu, Yun-Fan Chen and Tsung-Hsun Chuang
Molecules 2016, 21(12), 1713; https://doi.org/10.3390/molecules21121713 - 21 Dec 2016
Cited by 2 | Viewed by 5056
Abstract
A new strategy for cyclopenta[b]furan synthesis mediated by hypervalent iodine(III) has been described. The approach employs diacetoxyiodobenzene-induced initial dehydrogenation to a putative trienone intermediate and triggered sequential cycloisomerization to form the cyclo-penta[b]furan targets. Full article
(This article belongs to the Special Issue Hypervalent Iodine Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>ORTEP plot of X-ray crystallographic data for <b>4b</b>.</p>
Full article ">Scheme 1
<p>Routes for the synthesis of cyclopenta[<span class="html-italic">b</span>]furans.</p>
Full article ">Scheme 2
<p>Synthetic plans for the synthesis of cyclopenta[<span class="html-italic">b</span>]furan derivatives <b>1</b>.</p>
Full article ">Scheme 3
<p>Plausible Mechanism.</p>
Full article ">
562 KiB  
Article
Comparative Study on the Characteristics of Weissella cibaria CMU and Probiotic Strains for Oral Care
by Hye-Jin Jang, Mi-Sun Kang, Sung-Hun Yi, Ji-Young Hong and Sang-Pil Hong
Molecules 2016, 21(12), 1752; https://doi.org/10.3390/molecules21121752 - 20 Dec 2016
Cited by 46 | Viewed by 7849
Abstract
Probiotics have been demonstrated as a new paradigm to substitute antibiotic treatment for dental caries, gingivitis, and chronic periodontitis. The present work was conducted to compare the characteristics of oral care probiotics: Weissella cibaria CMU (Chonnam Medical University) and four commercial probiotic strains. [...] Read more.
Probiotics have been demonstrated as a new paradigm to substitute antibiotic treatment for dental caries, gingivitis, and chronic periodontitis. The present work was conducted to compare the characteristics of oral care probiotics: Weissella cibaria CMU (Chonnam Medical University) and four commercial probiotic strains. Survival rates under poor oral conditions, acid production, hydrogen peroxide production, as well as inhibition of biofilm formation, coaggregation, antibacterial activity, and inhibition of volatile sulfur compounds were evaluated. The viability of W. cibaria CMU was not affected by treatment of 100 mg/L lysozyme for 90 min and 1 mM hydrogen peroxide for 6 h. Interestingly, W. cibaria produced less acid and more hydrogen peroxide than the other four probiotics. W. cibaria inhibited biofilm formation by Streptococcus mutans at lower concentrations (S. mutans/CMU = 8) and efficiently coaggregated with Fusobacterium nucleatum. W. cibaria CMU and two commercial probiotics, including Lactobacillus salivarius and Lactobacillus reuteri, showed high antibacterial activities (>97%) against cariogens (S. mutans and Streptococcus sobrinus), and against periodontopathogens (F. nucleatum and Porphyromonas gingivalis). All of the lactic acid bacterial strains in this study significantly reduced levels of hydrogen sulfide and methyl mercaptan produced by F. nucleatum and P. gingivalis (p < 0.05). These results suggest that W. cibaria CMU is applicable as an oral care probiotic. Full article
(This article belongs to the Special Issue Antibacterial Materials and Coatings)
Show Figures

Figure 1

Figure 1
<p>The survival level of oral probiotic strains after treatment with (<b>a</b>) 0.01% lysozyme (<span class="html-italic">w</span>/<span class="html-italic">v</span>), and (<b>b</b>) 1 mM hydrogen peroxide.</p>
Full article ">Figure 2
<p>Hydrogen peroxide production activity of probiotics.</p>
Full article ">
145 KiB  
Editorial
Natural Products in Anti-Obesity Therapy
by Filomena Conforti and Min-Hsiung Pan
Molecules 2016, 21(12), 1750; https://doi.org/10.3390/molecules21121750 - 20 Dec 2016
Cited by 14 | Viewed by 5066
Abstract
Obesity is regulated by genetic, endocrine, metabolic, neurological, pharmacological, environmental, and nutritional factors. [...]
Full article
(This article belongs to the Special Issue Natural Products in Anti-Obesity Therapy)
1510 KiB  
Review
Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases
by Caroline Coisne, Sébastien Tilloy, Eric Monflier, Daniel Wils, Laurence Fenart and Fabien Gosselet
Molecules 2016, 21(12), 1748; https://doi.org/10.3390/molecules21121748 - 20 Dec 2016
Cited by 94 | Viewed by 12774
Abstract
Cardiovascular diseases, like atherosclerosis, and neurodegenerative diseases affecting the central nervous system (CNS) are closely linked to alterations of cholesterol metabolism. Therefore, innovative pharmacological approaches aiming at counteracting cholesterol imbalance display promising therapeutic potential. However, these approaches need to take into account the [...] Read more.
Cardiovascular diseases, like atherosclerosis, and neurodegenerative diseases affecting the central nervous system (CNS) are closely linked to alterations of cholesterol metabolism. Therefore, innovative pharmacological approaches aiming at counteracting cholesterol imbalance display promising therapeutic potential. However, these approaches need to take into account the existence of biological barriers such as intestinal and blood-brain barriers which participate in the organ homeostasis and are major defense systems against xenobiotics. Interest in cyclodextrins (CDs) as medicinal agents has increased continuously based on their ability to actively extract lipids from cell membranes and to provide suitable carrier system for drug delivery. Many novel CD derivatives are constantly generated with the objective to improve CD bioavailability, biocompatibility and therapeutic outcomes. Newly designed drug formulation complexes incorporating CDs as drug carriers have demonstrated better efficiency in treating cardiovascular and neurodegenerative diseases. CD-based therapies as cholesterol-sequestrating agent have recently demonstrated promising advances with KLEPTOSE® CRYSMEB in atherosclerosis as well as with the 2-hydroxypropyl-β-cyclodextrin (HPβCD) in clinical trials for Niemann-Pick type C disease. Based on this success, many investigations evaluating the therapeutical beneficial of CDs in Alzheimer’s, Parkinson’s and Huntington’s diseases are currently on-going. Full article
(This article belongs to the Special Issue Cyclodextrin Chemistry)
Show Figures

Figure 1

Figure 1
<p>Impact of β-CDs on reverse cholesterol transfer (RCT) and in atherosclerosis. As showed in <a href="#molecules-21-01748-t002" class="html-table">Table 2</a>, β-CD family shows promising therapeutic properties in atherosclerosis field. β-CDs are able to extract cholesterol and phospholipids from cell membrane (1) resulting in the decrease of lipid intracellular pools (2). This process leads to an activation of the liver X signaling (LXR) pathway (3) which in turn regulates the expression of ABCA1 and ABCG1 (4). As a consequence, the formation and lipidation of HDL particles are modified (5 and 6). In vitro, lipid extraction by CDs provokes a down-regulation of ABCA1 and ABCG1 expression and a decrease in the free cholesterol transfer to ApoA-I [<a href="#B12-molecules-21-01748" class="html-bibr">12</a>,<a href="#B13-molecules-21-01748" class="html-bibr">13</a>]. However, in tissues from ApoE<sup>−/−</sup> animals or when cells are cholesterol-loaded in vitro, lipid extraction induces an increase in the cholesterol efflux mediated by the up-regulation of these ABC transporters [<a href="#B13-molecules-21-01748" class="html-bibr">13</a>] (7). Noteworthy, in brain, apolipoprotein E remains the main cholesterol acceptor forming HDL. CD-mediated activation of LXR pathway inhibits inflammatory response (8) [<a href="#B11-molecules-21-01748" class="html-bibr">11</a>,<a href="#B13-molecules-21-01748" class="html-bibr">13</a>]. In addition, CDs promote atherosclerotic size plaque reduction in vivo (9) by a HDL-independent mechanism which remains unclear [<a href="#B11-molecules-21-01748" class="html-bibr">11</a>,<a href="#B13-molecules-21-01748" class="html-bibr">13</a>]. HDL: High density lipoproteins; LXR: Liver X receptor; ApoA-I/ApoE: Apolipoproteins A-I and E.</p>
Full article ">Figure 2
<p>Molecular mechanisms mediated by β-CDs in Alzheimer’s, Parkinson’s, Hugtington’s, Niemann-Pick Type C diseases. Niemann-Pick Type C disease is characterized by intracellular accumulation of unesterified cholesterol and glycosphingolipids. Alzheimer’s, Parkinson’s and Huntington’s diseases are charaterized by abnormal aggregation of peptides leading to the neurodegenerative processes. β-CD family acts at several levels and shows beneficial effects in these neurodegenerative diseases.</p>
Full article ">
1208 KiB  
Review
A Review of the Botany, Phytochemistry, Pharmacology and Toxicology of Rubiae Radix et Rhizoma
by Mingqiu Shan, Sheng Yu, Hui Yan, Peidong Chen, Li Zhang and Anwei Ding
Molecules 2016, 21(12), 1747; https://doi.org/10.3390/molecules21121747 - 20 Dec 2016
Cited by 39 | Viewed by 8717
Abstract
Rubia cordifolia Linn (Rubiaceae) is a climbing perennial herbal plant, which is widely distributed in China and India. Its root and rhizome, Rubiae Radix et Rhizoma (called Qiancao in China and Indian madder in India), is a well known phytomedicine used for hematemesis, [...] Read more.
Rubia cordifolia Linn (Rubiaceae) is a climbing perennial herbal plant, which is widely distributed in China and India. Its root and rhizome, Rubiae Radix et Rhizoma (called Qiancao in China and Indian madder in India), is a well known phytomedicine used for hematemesis, epistaxis, flooding, spotting, traumatic bleeding, amenorrhea caused by obstruction, joint impediment pain, swelling and pain caused by injuries from falls. In addition, it is a kind of pigment utilized as a food additive and a dye for wool or fiber. This review mainly concentrates on studies of the botany, phytochemistry, pharmacology and toxicology of this Traditional Chinese Medicine. The phytochemical evidences indicated that over a hundred chemical components have been found and isolated from the medicine, such as anthraquinones, naphthoquinones, triterpenoids, cyclic hexapeptides and others. These components are considered responsible for the various bioactivities of the herbal drug, including anti-oxidation, anti-inflammation, immunomodulation, antitumor, effects on coagulation-fibrinolysis system, neuroprotection and other effects. Additionally, based on these existing results, we also propose some interesting future research directions. Consequently, this review should help us to more comprehensively understand and to more fully utilize the herbal medicine Rubiae Radix et Rhizoma. Full article
(This article belongs to the Collection Herbal Medicine Research)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p><span class="html-italic">Rubia cordifolia</span> Linn (<b>A</b>) and Rubiae Radix <span class="html-italic">et</span> Rhizoma (<b>B</b>).</p>
Full article ">Figure 2
<p>Structures of anthraquinones in Rubiae Radix <span class="html-italic">et</span> Rhizoma.</p>
Full article ">Figure 3
<p>Structures of naphthoquinones in Rubiae Radix <span class="html-italic">et</span> Rhizoma.</p>
Full article ">Figure 4
<p>Structures of cyclic hexapeptides in Rubiae Radix <span class="html-italic">et</span> Rhizoma.</p>
Full article ">
1331 KiB  
Article
Effects of Quercetin in a Rat Model of Hemorrhagic Traumatic Shock and Reperfusion
by Virginia Chamorro, Rachele Pandolfi, Laura Moreno, Bianca Barreira, Andrea Martínez-Ramas, Daniel Morales-Cano, Jesús Ruiz-Cabello, José Angel Lorente, Juan Duarte, Ángel Cogolludo, José Luis Alvarez-Sala and Francisco Perez-Vizcaino
Molecules 2016, 21(12), 1739; https://doi.org/10.3390/molecules21121739 - 20 Dec 2016
Cited by 11 | Viewed by 5676
Abstract
Background: We hypothesized that treatment with quercetin could result in improved hemodynamics, lung inflammatory parameters and mortality in a rat model of hemorrhagic shock. Methods: Rats were anesthetized (80 mg/kg ketamine plus 8 mg/kg xylazine i.p.). The protocol included laparotomy for 15 min [...] Read more.
Background: We hypothesized that treatment with quercetin could result in improved hemodynamics, lung inflammatory parameters and mortality in a rat model of hemorrhagic shock. Methods: Rats were anesthetized (80 mg/kg ketamine plus 8 mg/kg xylazine i.p.). The protocol included laparotomy for 15 min (trauma), hemorrhagic shock (blood withdrawal to reduce the mean arterial pressure to 35 mmHg) for 75 min and resuscitation by re-infusion of all the shed blood plus lactate Ringer for 90 min. Intravenous quercetin (50 mg/kg) or vehicle were administered during resuscitation. Results: There was a trend for increased survival 84.6% (11/13) in the treated group vs. the shock group 68.4% (13/19, p > 0.05 Kaplan–Meier). Quercetin fully prevented the development of lung edema. The activity of aSMase was increased in the shock group compared to the sham group and the quercetin prevented this effect. However, other inflammatory markers such as myeloperoxidase activity, interleukin-6 in plasma or bronchoalveolar fluid were similar in the sham and shock groups. We found no bacterial DNA in plasma in these animals. Conclusions: Quercetin partially prevented the changes in blood pressure and lung injury in shock associated to hemorrhage and reperfusion. Full article
(This article belongs to the Special Issue Flavonoids: From Structure to Health Issues)
Show Figures

Figure 1

Figure 1
<p>Kaplan–Meier survival analysis during the reperfusion period. Anaesthetized animals were submitted to shock and at time 90 they were reperfused with blood plus lactate Ringer and with vehicle or quercetin, and followed for an additional period of 90 min. * <span class="html-italic">p</span> &lt; 0.05 vs. sham (log-rank test).</p>
Full article ">Figure 2
<p>Changes in (<b>A</b>) mean arterial blood pressure and (<b>B</b>) heart rate in the three experimental groups. Rats were subjected to laparotomy followed by controlled hypotension (shock phase) and then by resuscitation with lactate Ringer solution, shed blood and the quercetin or vehicle. Data are shown as the mean ± S.E.M. * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 vs. sham group during reperfusion (Dunnett’s test).</p>
Full article ">Figure 3
<p>aSMase activity. Measurements were made in lung homogenate for a total time of 30 min expressed as nmol/min/mL. * <span class="html-italic">p</span> &lt; 0.05 vs. sham group. Box-and-whisker plot showing medians with interquartile range and minimum and maximum values.</p>
Full article ">Figure 4
<p>Arterial blood gases. (<b>A</b>) Values of pH; (<b>B</b>) carbon dioxide partial pressure (pCO<sub>2</sub>); (<b>C</b>) excess base; (<b>D</b>) bicarbonate (HCO<sub>3</sub><sup>−</sup>); (<b>E</b>) total carbon dioxide concentration (TCO<sub>2</sub>); (<b>F</b>) arterial oxygen saturation (SO<sub>2</sub>) and (<b>G</b>) arterial oxygen partial pressure (pO<sub>2</sub>) in the sham, shock and shock + quercetin at 180 min (at the end of reperfusion). Box-and-whisker plot showing medians with interquartile range and minimum and maximum values. * <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01 vs. sham group.</p>
Full article ">Figure 5
<p>Markers of inflammation and vascular permeability: (<b>A</b>) Edema (wet to dry weight ratio); (<b>B</b>) proteins in Bronchoalveolar Lavage Fluid (BALF); (<b>C</b>) IgM BALF/plasma ratio (<b>D</b>) cells in BALF; (<b>E</b>) Myeloperoxidase (MPO) activity and (<b>F</b>) IL-6 in BALF measured at the end of reperfusion. Box-and-whisker plot showing medians with interquartile range and minimum and maximum values in each group. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 and *** <span class="html-italic">p</span> &lt; 0.005 vs. sham group.</p>
Full article ">Figure 5 Cont.
<p>Markers of inflammation and vascular permeability: (<b>A</b>) Edema (wet to dry weight ratio); (<b>B</b>) proteins in Bronchoalveolar Lavage Fluid (BALF); (<b>C</b>) IgM BALF/plasma ratio (<b>D</b>) cells in BALF; (<b>E</b>) Myeloperoxidase (MPO) activity and (<b>F</b>) IL-6 in BALF measured at the end of reperfusion. Box-and-whisker plot showing medians with interquartile range and minimum and maximum values in each group. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 and *** <span class="html-italic">p</span> &lt; 0.005 vs. sham group.</p>
Full article ">
1852 KiB  
Review
Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor Treatment
by Chendi Ding, Ling Tong, Jing Feng and Jiajun Fu
Molecules 2016, 21(12), 1715; https://doi.org/10.3390/molecules21121715 - 20 Dec 2016
Cited by 121 | Viewed by 13267
Abstract
Benefiting from the development of nanotechnology, drug delivery systems (DDSs) with stimuli-responsive controlled release function show great potential in clinical anti-tumor applications. By using a DDS, the harsh side effects of traditional anti-cancer drug treatments and damage to normal tissues and organs can [...] Read more.
Benefiting from the development of nanotechnology, drug delivery systems (DDSs) with stimuli-responsive controlled release function show great potential in clinical anti-tumor applications. By using a DDS, the harsh side effects of traditional anti-cancer drug treatments and damage to normal tissues and organs can be avoided to the greatest extent. An ideal DDS must firstly meet bio-safety standards and secondarily the efficiency-related demands of a large drug payload and controlled release function. This review highlights recent research progress on DDSs with stimuli-responsive characteristics. The first section briefly reviews the nanoscale scaffolds of DDSs, including mesoporous nanoparticles, polymers, metal-organic frameworks (MOFs), quantum dots (QDs) and carbon nanotubes (CNTs). The second section presents the main types of stimuli-responsive mechanisms and classifies these into two categories: intrinsic (pH, redox state, biomolecules) and extrinsic (temperature, light irradiation, magnetic field and ultrasound) ones. Clinical applications of DDS, future challenges and perspectives are also mentioned. Full article
(This article belongs to the Special Issue Stimuli-Responsive Biomaterials in Biomedical Applications)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>General working mechanism of drug delivery systems (DDSs).</p>
Full article ">Figure 2
<p>Schematic diagram of different types of gate strategies. Adapted with permission from [<a href="#B83-molecules-21-01715" class="html-bibr">83</a>,<a href="#B86-molecules-21-01715" class="html-bibr">86</a>,<a href="#B87-molecules-21-01715" class="html-bibr">87</a>,<a href="#B88-molecules-21-01715" class="html-bibr">88</a>,<a href="#B89-molecules-21-01715" class="html-bibr">89</a>]. Copyright 2010, 2015, 2003, 2015, 2016 American Chemical Society.</p>
Full article ">Figure 3
<p>Schematic diagram of a macrocyclic molecule derivative plug gate. DOX, doxorubicin; GEM, gemcitabine. Reprinted with permission from [<a href="#B94-molecules-21-01715" class="html-bibr">94</a>]. Copyright 2015 American Chemical Society.</p>
Full article ">Figure 4
<p>Schematic diagram of a polymer DDS. Reprinted with permission from [<a href="#B105-molecules-21-01715" class="html-bibr">105</a>]. Copyright 2013 American Chemical Society.</p>
Full article ">
2721 KiB  
Article
Targeting Cancer Stem Cells with Novel 4-(4-Substituted phenyl)-5-(3,4,5-trimethoxy/3,4-dimethoxy)-benzoyl-3,4-dihydropyrimidine-2(1H)-one/thiones
by Mashooq Ahmad Bhat, Abdullah Al-Dhfyan and Mohamed A. Al-Omar
Molecules 2016, 21(12), 1746; https://doi.org/10.3390/molecules21121746 - 19 Dec 2016
Cited by 24 | Viewed by 5986
Abstract
Novel 4-(4-substituted phenyl)-5-(3,4,5-trimethoxy/3,4-dimethoxy)-benzoyl-3,4-dihydropyrimidine-2(1H)-one/thione derivatives (DHP 19) were designed, synthesized, characterized and evaluated for antitumor activity against cancer stem cells. The compounds were synthesized in one pot. Enaminones E1 and E2 were reacted with substituted benzaldehydes and urea/thiourea [...] Read more.
Novel 4-(4-substituted phenyl)-5-(3,4,5-trimethoxy/3,4-dimethoxy)-benzoyl-3,4-dihydropyrimidine-2(1H)-one/thione derivatives (DHP 19) were designed, synthesized, characterized and evaluated for antitumor activity against cancer stem cells. The compounds were synthesized in one pot. Enaminones E1 and E2 were reacted with substituted benzaldehydes and urea/thiourea in the presence of glacial acetic acid. The synthesized compounds were characterized by spectral analysis. The compounds were screened in vitro against colon cancer cell line (LOVO) colon cancer stem cells. Most of the compounds were found to be active against side population cancer stem cells with an inhibition of >50% at a 10 μM concentration. Compounds DHP-1, DHP-7 and DHP-9 were found to be inactive. Compound DHP-5 exhibited an in vitro anti-proliferative effect and arrested cancer cells at the Gap 2 phase (G2) checkpoint and demonstrated an inhibitory effect on tumor growth for a LOVO xenograft in a nude mouse experiment. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Dihydropyrimidine derivatives demonstrating anticancer activity.</p>
Full article ">Figure 2
<p>Lead compound Monstrol-97 and newly synthesized compounds (<b>DHP 1</b>–<b>9</b>).</p>
Full article ">Figure 3
<p>Scatter plot showing results of side population analyses of tumor-derived cells of LOVO untreated, treated with <b>DHP-1</b>, <b>DHP-4</b>, <b>DHP-5</b> and <b>DHP-6</b>. Furthermore, compound <b>DHP-5</b> exhibit an in vitro anti-proliferative effect and arrested cancer cells at the G2 checkpoint (<a href="#molecules-21-01746-f004" class="html-fig">Figure 4</a>). Blue color represents the percentage of cancer stem cells and red color represents the percentage of remaining cells other than cancer stem cells.</p>
Full article ">Figure 4
<p>Compound <b>DHP-5</b> arrested cancer cells at G2 checkpoint.</p>
Full article ">Figure 5
<p>Scatter plot showing results of side population analyses of tumor-derived cells of the LOVO xenograft that were untreated, treated with side population inhibitor reference drug Verapamil (200 μM) and with <b>DHP-5</b> (50 μM).</p>
Full article ">Figure 6
<p>Graph showing tumor growth record of LOVO (colon cancer xenograft) in untreated mice group (<b>red line</b>) and <b>DHP-5</b>–treated (50 mg/kg) mice group (<b>blue line</b>).</p>
Full article ">Scheme 1
<p>Synthetic route of compounds (<b>DHP 1</b>–<b>9</b>).</p>
Full article ">
906 KiB  
Article
Characterization of Fractional Polysaccharides from Gleditsia sinensis and Gleditsia microphylla Gums
by Yantao Liu, Zhenglong Xu, Weian Zhang, Jiufang Duan, Jianxin Jiang and Dafeng Sun
Molecules 2016, 21(12), 1745; https://doi.org/10.3390/molecules21121745 - 19 Dec 2016
Cited by 20 | Viewed by 5584
Abstract
The seeds of Gleditsia sinensis and Gleditsia microphylla, widespread in China, are an important source of galactomannans. G. sinensis gum (GSG) and G. microphylla gum (GMG) were purified and precipitated using different concentrations of ethanol and isopropanol. The GSG and GMG, precipitated [...] Read more.
The seeds of Gleditsia sinensis and Gleditsia microphylla, widespread in China, are an important source of galactomannans. G. sinensis gum (GSG) and G. microphylla gum (GMG) were purified and precipitated using different concentrations of ethanol and isopropanol. The GSG and GMG, precipitated in different stages, presented different characteristics, including polymer recovery, mannose/galactose ratio, chemical composition, molecular weight, and morphological appearance. The galactomannan recovery of GSG and GMG in 33.3% ethanol was 81.7% and 82.5%, respectively, while that in 28.8% isopropanol was 81.3% and 82.9%, respectively. To achieve similar precipitation efficiency, the amount of isopropanol should be lower than that of ethanol because of the lower dielectric constant of isopropanol (20 vs. 25 for ethanol). The precipitation behavior of galactomannans in polar organic solvents was dependent on the molecular structures and properties of the solvent. A higher mannose/galactose ratio and a higher molecular weight was obtained in a lower concentration of alcohols. Full article
(This article belongs to the Special Issue Natural Polysaccharides)
Show Figures

Figure 1

Figure 1
<p>Flow curves of 0.5% (<span class="html-italic">w</span>/<span class="html-italic">w</span>) aqueous solutions of GSG (<b>a</b>) and GMG (<b>b</b>) at 30 °C.</p>
Full article ">Figure 2
<p>Galactomannan recovery yield and M/G ratio of the gum fractions of GSG and GMG precipitated by (<b>a</b>) ethanol and (<b>b</b>) isopropanol. Numbers over the bars represent the M/G ratios.</p>
Full article ">Figure 3
<p>Normalized wet mass ratio and galactomannan concentration of the gum fractions of GSG and GMG obtained from (<b>a</b>) ethanol and (<b>b</b>) isopropanol precipitation.</p>
Full article ">Figure 4
<p>Scheme of the fractional precipitation of the two galactomannan gums of with ethanol and isopropanol.</p>
Full article ">
1929 KiB  
Article
Combined Use of S. pombe and L. thermotolerans in Winemaking. Beneficial Effects Determined Through the Study of Wines’ Analytical Characteristics
by Ángel Benito, Fernando Calderón and Santiago Benito
Molecules 2016, 21(12), 1744; https://doi.org/10.3390/molecules21121744 - 18 Dec 2016
Cited by 56 | Viewed by 6597
Abstract
The most common way to produce red wine is through the use of Saccharomyces cerevisiae strains for alcoholic fermentation and lactic acid bacteria for malolactic fermentation. This traditional winemaking methodology produces microbiologically stable red wines. However, under specific conditions off-flavours can occur, wine [...] Read more.
The most common way to produce red wine is through the use of Saccharomyces cerevisiae strains for alcoholic fermentation and lactic acid bacteria for malolactic fermentation. This traditional winemaking methodology produces microbiologically stable red wines. However, under specific conditions off-flavours can occur, wine quality can suffer and human health problems are possible, especially after the second fermentation by the lactic acid bacteria. In warm countries, problems during the malolactic fermentation arise because of the high pH of the must, which makes it very difficult to properly control the process. Under such conditions, wines with high acetic acid and histamine concentrations are commonly produced. This study investigates a recent red
wine-making technology that uses a combination of Lachancea thermotolerans and Schizosaccharomyces pombe as an alternative to the conventional malolactic fermentation. This work studies new parameters such as aroma compounds, amino acids, ethanol index and sensory evaluation. Schizosaccharomyces pombe totally consumes malic acid while Lachancea thermotolerans produces lactic acid, avoiding excessive deacidification of musts with low acidity in warm viticulture areas. This methodology also reduces the malolactic fermentation hazards in wines with low acidity. The main products are wines that contain less acetic acid, less biogenic amines and precursors and less ethyl carbamate precursors than the traditional wines produced via conventional fermentation techniques. Full article
(This article belongs to the Section Natural Products Chemistry)
Show Figures

Figure 1

Figure 1
<p>Population development during fermentation of <span class="html-italic">Saccharomyces cerevisiae</span> 88 alone (SC; <b>A</b>), sequential fermentation with <span class="html-italic">Saccharomyces cerevisiae</span> 88 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SC; <b>B</b>), sequential fermentation with <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SK; <b>C</b>) and <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 alone (SK; <b>D</b>).</p>
Full article ">Figure 1 Cont.
<p>Population development during fermentation of <span class="html-italic">Saccharomyces cerevisiae</span> 88 alone (SC; <b>A</b>), sequential fermentation with <span class="html-italic">Saccharomyces cerevisiae</span> 88 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SC; <b>B</b>), sequential fermentation with <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SK; <b>C</b>) and <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 alone (SK; <b>D</b>).</p>
Full article ">Figure 2
<p>Fermentation kinetics of glucose + fructose for <span class="html-italic">Saccharomyces cerevisiae</span> 88 alone (SC), a sequential fermentation with <span class="html-italic">Saccharomyces cerevisiae</span> 88 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SC), a sequential fermentation with <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SK) and <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 alone (SK).</p>
Full article ">Figure 3
<p>Fermentation kinetics of L-malic acid for <span class="html-italic">Saccharomyces cerevisiae</span> 88 alone (SC), a sequential fermentation with <span class="html-italic">Saccharomyces cerevisiae</span> 88 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SC), a sequential fermentation with <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SK) and <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 alone (SK).</p>
Full article ">Figure 4
<p>Fermentation kinetics of L-lactic acid for <span class="html-italic">Saccharomyces cerevisiae</span> 88 alone (SC), a sequential fermentation with <span class="html-italic">Saccharomyces cerevisiae</span> 88 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SC), a sequential fermentation with <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SK) and <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 alone (SK).</p>
Full article ">Figure 5
<p>Fermentation kinetics of pyruvic acid for <span class="html-italic">Saccharomyces cerevisiae</span> 88 alone (SC), sequential fermentation with <span class="html-italic">Saccharomyces cerevisiae</span> 88 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SC), a sequential fermentation with <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SK) and <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 alone (SK).</p>
Full article ">Figure 6
<p>Results of the ethanol index analysis of bottled wines from different fermentation processes of <span class="html-italic">Saccharomyces cerevisiae</span> 88 alone (SC), sequential fermentation with <span class="html-italic">Saccharomyces cerevisiae</span> 88 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SC), sequential fermentation with <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SK), <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 alone (SK), and fermentations after malolactic fermentation with <span class="html-italic">Oenococcus oeni</span> 217 (+ MLF).</p>
Full article ">Figure 7
<p>Results of the sensory analysis of bottled wines from different fermentation processes of <span class="html-italic">Saccharomyces cerevisiae</span> 88 alone (SC), sequential fermentation with <span class="html-italic">Saccharomyces cerevisiae</span> 88 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SC), sequential fermentation with <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 and <span class="html-italic">Lachancea thermotolerans</span> CONCERTO™ (LT…SK), <span class="html-italic">Schizosaccharomyces pombe</span> 4.5 alone (SK), and fermentations after malolactic fermentation with <span class="html-italic">Oenococcus oeni</span> 217 (+ MLF). The intensity of the 12 attributes was scaled from 0 (no character) to 10 (very strong character).</p>
Full article ">
3639 KiB  
Article
Chemical Basis of the Fungicidal Activity of Tobacco Extracts against Valsa mali
by Chemical Basis of the Fungicidal Activity of Tobacco Extracts against Valsa mali Suzhen Duan, Yongmei Du, Xiaodong Hou, Ning Yan, Weijie Dong, Xinxin Mao and Zhongfeng Zhang
Molecules 2016, 21(12), 1743; https://doi.org/10.3390/molecules21121743 - 18 Dec 2016
Cited by 32 | Viewed by 6097
Abstract
Under pressure from social criticism and an unclear future, tobacco researchers have begun to seek alternative uses for the product. Here, we present our study on isolating tobacco compounds with fungicidal activity, which could be used as plant-derived pesticides. Using
Valsa mali as [...] Read more.
Under pressure from social criticism and an unclear future, tobacco researchers have begun to seek alternative uses for the product. Here, we present our study on isolating tobacco compounds with fungicidal activity, which could be used as plant-derived pesticides. Using
Valsa mali as the target fungus, agar plate tests were conducted to evaluate the fungicidal activity of various tobacco extracts, including tobacco leaves extracts prepared with different solvents, extracts of different tobacco cultivars, and samples from different tobacco organs. Fungal growth morphology was used as the criterion to evaluate the fungicidal activity of tobacco extracts. Correlation analyses between the fungicidal activities and the chemical components of tobacco extracts indicated the major chemical constituents with fungicidal activity. Then, the active compounds were isolated and their effects on the ultra-microstructures of V. mali was analyzed using scanning- and transmission-electron microscopy. The results suggested that tobacco extracts prepared with solvents of weaker polarity had higher fungicidal activity, and the inhibitory activity of tobacco extracts against V. mali was also cultivar dependent. Furthermore, the fungicidal effects of tobacco flower extracts were higher than those of the leaf extracts. Chemical analysis indicated that cembranoids were the main fungicidal substances, which act by destroying the endometrial structure of the fungus. Tobacco cembranoids at 80 μg/mL could completely inhibit the growth of V. mali, with an EC50 value of 13.18 μg/mL. Our study therefore suggests that tobacco leaves and inflorescences are excellent plant resources for the biological control of V. mali. Full article
Show Figures

Figure 1

Figure 1
<p>Inhibitory rate against <span class="html-italic">V. mali</span> and the concentration of terpenes of tobacco leaf extracts obtained using different solvents. Columns with different letters represent significantly different extraction solvents according to Duncan’s multiple range tests at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 2
<p>Inhibitory rate against <span class="html-italic">V. mali</span> and the concentration of terpenes in different tobacco variety extracts. Columns with different letters represent varieties with significantly different values according to Duncan’s multiple range tests at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 3
<p>Inhibitory rate against <span class="html-italic">V. mali</span> and the concentration of terpenes in tobacco flower and leaf <span class="html-italic">n</span>-hexane extracts. Columns with different letters represent organs with significantly different values according to Duncan’s multiple range tests at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 4
<p>Total ion chromatogram of the tobacco cembranoids extract. Peaks 1, 2, 3, and 4 represent tobacco cembranoids.</p>
Full article ">Figure 5
<p>Inhibitory effect of 95% ethanol (<b>A</b>) and tobacco cembranoids extract (<b>B</b>) on <span class="html-italic">V. mali</span>.</p>
Full article ">Figure 6
<p>Ergosterol content of untreated and treated <span class="html-italic">V. mali</span> hyphal cell membranes. Peak 1: The content of ergosterol in membranes treated with 40 μg/mL (working concentration) tobacco cembranoids extract; Peak 2: Ergosterol content following 20 μg/mL (working concentration) treatment; Peak 3: Ergosterol content following treatment 95% ethanol (control).</p>
Full article ">Figure 7
<p>Scanning electron microscopy images of untreated and treated <span class="html-italic">V. mali</span> hyphal structure. The untreated hypha appeared round and plump, with structural integrity. (<b>A</b>) 800×; (<b>C</b>) 3000×. After treatment with 40 μg/mL (working concentration) cembranoids extract, the hypha was deformed, showing adhesion and obvious septa. (<b>B</b>) 800×; (<b>D</b>) 3000×.</p>
Full article ">Figure 8
<p>Transmission electron microscopy images of untreated and treated <span class="html-italic">V. mali</span> hyphal structures (× 10 k). (<b>A</b>) Horizontal and (<b>C</b>) vertical sections of untreated hyphal structures show regular, uniform cytoplasm; (<b>B</b>) Horizontal and (<b>D</b>) vertical sections of structures following 40 μg/mL (working concentration) cembranoids extract treatment. It can be observed that the cell wall became distorted, the plasma membrane was unevenly thickened, and the intracellular composition was disordered.</p>
Full article ">
2435 KiB  
Article
Antimicrobial Activity and Urease Inhibition of Schiff Bases Derived from Isoniazid and Fluorinated Benzaldehydes and of Their Copper(II) Complexes
by Ladislav Habala, Samuel Varényi, Andrea Bilková, Peter Herich, Jindra Valentová, Jozef Kožíšek and Ferdinand Devínsky
Molecules 2016, 21(12), 1742; https://doi.org/10.3390/molecules21121742 - 17 Dec 2016
Cited by 28 | Viewed by 7724
Abstract
In order to evaluate the influence of substitution on biological properties of Schiff bases and their metal complexes, a series of differently substituted fluorine-containing Schiff bases starting from the drug isoniazid (isonicotinylhydrazide) were prepared and their structures were established by single-crystal X-ray diffraction. [...] Read more.
In order to evaluate the influence of substitution on biological properties of Schiff bases and their metal complexes, a series of differently substituted fluorine-containing Schiff bases starting from the drug isoniazid (isonicotinylhydrazide) were prepared and their structures were established by single-crystal X-ray diffraction. Also, four copper(II) complexes of these Schiff bases were synthesized. The prepared compounds were evaluated for their antimicrobial activity and urease inhibition. Two of the Schiff bases exerted activity against C. albicans. All copper(II) complexes showed excellent inhibitory properties against jack bean urease, considerably better than that of the standard inhibitor acetohydroxamic acid. Full article
(This article belongs to the Special Issue Metal Based Drugs: Opportunities and Challenges)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The molecular structure of ligands (<b>L1</b>–<b>L4</b>), showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level.</p>
Full article ">Figure 2
<p>The crystal packing of ligand <b>L1</b>, viewed along the b axis. Red dashed lines indicate hydrogen interactions.</p>
Full article ">Figure 3
<p>The crystal packing of ligand <b>L2</b>, viewed along the b axis. Red dashed lines indicate hydrogen interaction.</p>
Full article ">Figure 4
<p>The crystal packing of ligand <b>L3</b>, viewed along the b axis. Red dashed lines indicate hydrogen interactions.</p>
Full article ">Figure 5
<p>The crystal packing of ligand <b>L4</b>, viewed along the b axis. Red dashed lines indicate hydrogen interactions.</p>
Full article ">Scheme 1
<p>Synthesis of the Schiff bases <b>L1</b>–<b>L6</b> (<b>L1</b>: R<sup>2</sup> = CF<sub>3</sub>, R<sup>1</sup> = R<sup>3</sup> = R<sup>4</sup> = H; <b>L2</b>: R<sup>4</sup> = CF<sub>3</sub>, R<sup>1</sup> = R<sup>2</sup> = R<sup>3</sup> = H; <b>L3</b>: R<sup>2</sup> = F, R<sup>1</sup> = R<sup>3</sup> = R<sup>4</sup> = H; <b>L4</b>: R<sup>1</sup> = F, R<sup>4</sup> = OH, R<sup>2</sup> = R<sup>3</sup> = H; <b>L5</b>: R<sup>3</sup> = F, R<sup>4</sup> = OH, R<sup>1</sup> = R<sup>2</sup> = H; <b>L6</b>: R<sup>1</sup> = R<sup>2</sup> = R<sup>3</sup> = R<sup>4</sup> = H).</p>
Full article ">
1974 KiB  
Article
DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents
by Shilpa Chooniedass, Rachelle L. Dillon, Arjune Premsukh, Peter J. Hudson, Gregory P. Adams, Glen C. MacDonald and Jeannick Cizeau
Molecules 2016, 21(12), 1741; https://doi.org/10.3390/molecules21121741 - 17 Dec 2016
Cited by 6 | Viewed by 5613
Abstract
Antibody drug conjugates (ADC), comprised of highly potent small molecule payloads chemically conjugated to a full-length antibody, represent a growing class of therapeutic agents. The targeting of cytotoxic payloads via the specificity and selectivity of the antibody has led to substantial clinical benefits. [...] Read more.
Antibody drug conjugates (ADC), comprised of highly potent small molecule payloads chemically conjugated to a full-length antibody, represent a growing class of therapeutic agents. The targeting of cytotoxic payloads via the specificity and selectivity of the antibody has led to substantial clinical benefits. However, ADC potency can be altered by mechanisms of resistance such as overexpression of efflux pumps or anti-apoptotic proteins. DeBouganin is a de-immunized variant of bouganin, a ribosome-inactivating protein (RIP) that blocks protein synthesis, thereby leading to apoptosis. When conjugated to trastuzumab (T-deB), deBouganin was more potent than ado-trastuzumab-emtansine (T-DM1) and unaffected by resistance mechanisms to which DM1 is susceptible. To further highlight the differentiating mechanism of action of deBouganin, HCC1419 and BT-474 tumor cells that survived T-DM1 or trastuzumab-MMAE (T-MMAE) treatment were treated with an anti-HER2 C6.5 diabody–deBouganin fusion protein or T-deB. C6.5 diabody–deBouganin and T-deB were potent against HCC1419 and BT-474 cells that were resistant to T-DM1 or T-MMAE killing. The resistant phenotype involved MDR pumps, Bcl-2 family members, and the presence of additional unknown pathways. Overall, the data suggest that deBouganin is effective against tumor cell resistance mechanisms selected in response to ADCs composed of anti-microtubule payloads. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Western Blot analysis of induced <span class="html-italic">E. coli</span> supernatants containing deB-C6.5-diab (lanes 1 and 2), C6.5-diab-deB (lanes 3 and 4), and C6.5-diab (lane 5) immunoblotted with an anti-His antibody; (<b>B</b>) Western Blot and Coomassie staining of purified deB-C6.5-diab (lanes 1 and 4), C6.5-diab-deB (lanes 2 and 5), and C6.5-diab (lanes 3 and 6). Purified samples resolved on an SDS-PAGE gel were either transferred to a nitrocellulose membrane and immunoblotted with an anti-His antibody (lanes 1, 2, and 3) or stained with Coomassie blue (lanes 4, 5, and 6); (<b>C</b>) SE-HPLC profile of purified deB-C6.5-diab with the retention time (6.745 min) indicated by the arrow; (<b>D</b>) Binding reactivity of C6.5-diab (dashed blue) and deB-C6.5-diab (black) against SK-BR-3 cells. Binding reactivity was determined by flow cytometry, as described in the Materials and Methods section; (<b>E</b>) Cytotoxicity of deB-C6.5-diab (dashed blue) and C6.5-diab-deB (black) against HER2-positive SK-BR-3 cells; (<b>F</b>) Kinetics of in vitro digestion of deB-C6.5-diab and C6.5-diab-deB by furin. Purified samples were incubated with recombinant furin enzyme for the indicated hours. Samples were then separated on an SDS-PAGE gel and stained with Coomassie Blue.</p>
Full article ">Figure 2
<p>(<b>A</b>) Cytotoxicity of deB-C6.5-diab (blue) and deB (black) against a panel of HER2 3+ cell lines. Cytotoxicity of deB-C6.5-diab (blue), T-DM1 (red), T-MMAE (green); and T-deB (purple) against SK-BR-3 (<b>B</b>); BT-474 (<b>C</b>); and HCC1419 (<b>D</b>) cells.</p>
Full article ">Figure 3
<p>Growth profiles of SK-BR-3 (<b>A</b>); HCC1419 (<b>B</b>); or BT-474 (<b>C</b>) cells surviving deB-C6.5-diab (blue), T-DM1 (red), T-MMAE (green) treatments, or untreated cells (black). Untreated cells or cells surviving deB-C6.5-diab, T-DM1, and T-MMAE treatments were harvested and recultured without drugs. Cell growth was measured as O.D.<sub>490</sub> using the Cell Titer 96 Aqueous One solution cell proliferation assay at three, five, eight, and 10 days, as described in the Materials and Methods section.</p>
Full article ">Figure 3 Cont.
<p>Growth profiles of SK-BR-3 (<b>A</b>); HCC1419 (<b>B</b>); or BT-474 (<b>C</b>) cells surviving deB-C6.5-diab (blue), T-DM1 (red), T-MMAE (green) treatments, or untreated cells (black). Untreated cells or cells surviving deB-C6.5-diab, T-DM1, and T-MMAE treatments were harvested and recultured without drugs. Cell growth was measured as O.D.<sub>490</sub> using the Cell Titer 96 Aqueous One solution cell proliferation assay at three, five, eight, and 10 days, as described in the Materials and Methods section.</p>
Full article ">Figure 4
<p>Cytotoxicity of deB-C6.5-diab (blue), T-DM1 (red), T-MMAE (green), and T-deB (purple) against HCC1419 cells surviving T-DM1 (<b>A</b>) or T-MMAE (<b>B</b>) treatments. Representative examples of two independent experiments.</p>
Full article ">Figure 5
<p>(<b>A</b>) Representative images of tumorospheres from untreated (NT) HCC1419 cells or cells treated with 10 nM deB-C6.5-diab, T-DM1, or T-MMAE. (<b>B</b>) Representative images of tumorospheres from HCC1419 cells surviving T-DM1 or T-MMAE treatment incubated under tumorosphere-forming conditions in the presence of 10 nM deB-C6.5-diab, T-DM1, or T-MMAE.</p>
Full article ">Figure 6
<p>(<b>A</b>) Western blot analysis of the expression of Bcl-xL and Mcl-1 in untreated (NT) HCC1419 cells or cells surviving T-DM1 or T-MMAE treatment. β-actin levels were monitored to ensure equal loading; (<b>B</b>) Cytotoxicity of T-DM1 (red) or T-MMAE (green) in the presence (dashed lines) or absence (solid lines) of ABT-737 against HCC1419 cells that survived T-DM1 (red) or T-MMAE (green) treatment.</p>
Full article ">Figure 7
<p>Role of BCRP in BT-474 cells that survived T-DM1 or T-MMAE treatments. (<b>A</b>) Cytotoxicity of T-DM1 and DM1 was measured against BT-474 cells (grey bars) and T-DM1 surviving BT-474 cells with (hashed bars) or without (black bars) 10 µM Ko143; (<b>B</b>) Cytotoxicity of T-MMAE and MMAE was measured against BT-474 (grey bars) and T-MMAE surviving BT-474 cells with (hashed bars) or without (black bars) 10 µM Ko143. * indicates significant difference (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
2866 KiB  
Article
Photochemically Immobilized 4-Methylbenzoyl Cellulose as a Powerful Chiral Stationary Phase for Enantioselective Chromatography
by Eric Francotte, Dan Huynh and Tong Zhang
Molecules 2016, 21(12), 1740; https://doi.org/10.3390/molecules21121740 - 17 Dec 2016
Cited by 14 | Viewed by 4820
Abstract
A process to immobilize para-methylbenzoyl cellulose (PMBC) on silica gel has been developed and applied to prepare chiral stationary phases (CSPs) for enantioselective chromatography. The immobilization was achieved by simple irradiation of the polysaccharide derivative with ultraviolet light after coating on a [...] Read more.
A process to immobilize para-methylbenzoyl cellulose (PMBC) on silica gel has been developed and applied to prepare chiral stationary phases (CSPs) for enantioselective chromatography. The immobilization was achieved by simple irradiation of the polysaccharide derivative with ultraviolet light after coating on a silica gel support. The influence of parameters such as irradiation time and solvent on immobilization effectiveness were investigated. The performance of the prepared immobilized phases were evaluated by injection of a series of racemic compounds onto the packed columns and determination of their chiral recognition ability. By contrast to the classical coated phase, the immobilized CSP can be used under various chromatographic conditions without limitation of organic solvent types as the mobile phase. This extended applicability permits to improve selectivity and to resolve chiral compounds which are not or only poorly soluble in the mobile phases which are compatible with the non-immobilized PMBC stationary phase. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic photochemical setup for immobilization of PMBC on silica gel.</p>
Full article ">Figure 2
<p>Structures of the tested racemic compounds.</p>
Full article ">Figure 3
<p>Chromatographic resolution of compound <b>16</b>. (<b>a</b>) on PMBC-S, mobile phase hexane/2-propanol 90/10 (<span class="html-italic">v</span>/<span class="html-italic">v</span>); (<b>b</b>) on PMBC-Im E, mobile phase hexane/2-propanol 90/10 (<span class="html-italic">v</span>/<span class="html-italic">v</span>); (<b>c</b>) on PMBC-Im E, mobile phase heptane/chloroform 75/25 (<span class="html-italic">v</span>/<span class="html-italic">v</span>).</p>
Full article ">Figure 4
<p>Chromatographic resolution of compound <b>1</b>–<b>19</b> on PMBC-Im E with heptane/chloroform as the mobile phase. Enantioselectivity vs. chloroform content in heptane.</p>
Full article ">Figure 5
<p>Chromatographic resolution of compounds <b>1</b>–<b>19</b> on PMBC-Im E with heptane/chloroform as the mobile phase. Retention factor k<sub>2</sub> vs. chloroform content in heptane.</p>
Full article ">Figure 6
<p>Chromatographic resolution of compound <b>19</b> on PMBC-Im E using heptane /chloroform mixtures as a mobile phase: (<b>a</b>) <span class="html-fig-inline" id="molecules-21-01740-i001"> <img alt="Molecules 21 01740 i001" src="/molecules/molecules-21-01740/article_deploy/html/images/molecules-21-01740-i001.png"/></span> 60/40 (<span class="html-italic">v</span>/<span class="html-italic">v</span>); (<b>b</b>) <span style="color:red">-----</span> 75/25 (<span class="html-italic">v</span>/<span class="html-italic">v</span>); and (<b>c</b>) <b>……</b> 90/10 (<span class="html-italic">v</span>/<span class="html-italic">v</span>).</p>
Full article ">Figure 7
<p>Chromatographic resolution of compound <b>6</b> on PMBC-Im E using heptane /chloroform mixtures as a mobile phase: (<b>a</b>) <span class="html-fig-inline" id="molecules-21-01740-i001"> <img alt="Molecules 21 01740 i001" src="/molecules/molecules-21-01740/article_deploy/html/images/molecules-21-01740-i001.png"/></span> 60/40 (<span class="html-italic">v</span>/<span class="html-italic">v</span>); (<b>b</b>) <span style="color:red">-----</span> 67.5/32.5 (<span class="html-italic">v</span>/<span class="html-italic">v</span>); and (<b>c</b>) <b>……</b> 75/25 (<span class="html-italic">v</span>/<span class="html-italic">v</span>).</p>
Full article ">
1067 KiB  
Article
Volatile and Nonvolatile Constituents and Antioxidant Capacity of Oleoresins in Three Taiwan Citrus Varieties as Determined by Supercritical Fluid Extraction
by Min-Hung Chen and Tzou-Chi Huang
Molecules 2016, 21(12), 1735; https://doi.org/10.3390/molecules21121735 - 17 Dec 2016
Cited by 33 | Viewed by 6595
Abstract
As local varieties of citrus fruit in Taiwan, Ponkan (Citrus reticulata Blanco), Tankan (C. tankan Hayata), and Murcott (C. reticulate × C. sinensis) face substantial competition on the market. In this study, we used carbon dioxide supercritical technology to [...] Read more.
As local varieties of citrus fruit in Taiwan, Ponkan (Citrus reticulata Blanco), Tankan (C. tankan Hayata), and Murcott (C. reticulate × C. sinensis) face substantial competition on the market. In this study, we used carbon dioxide supercritical technology to extract oleoresin from the peels of the three citrus varieties, adding alcohol as a solvent assistant to enhance the extraction rate. The supercritical fluid extraction was fractionated with lower terpene compounds in order to improve the oxygenated amounts of the volatile resins. The contents of oleoresin from the three varieties of citrus peels were then analyzed with GC/MS in order to identify 33 volatile compounds. In addition, the analysis results indicated that the non-volatile oleoresin extracted from the samples contains polymethoxyflavones (86.2~259.5 mg/g), limonoids (111.7~406.2 mg/g), and phytosterols (686.1~1316.4 μg/g). The DPPH (1,1-Diphenyl-2-picrylhydrazyl), ABTS [2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)] scavenging and inhibition of lipid oxidation, which test the oleoresin from the three kinds of citrus, exhibited significant antioxidant capacity. The component polymethoxyflavones contributed the greatest share of the overall antioxidant capacity, while the limonoid and phytosterol components effectively coordinated with its effects. Full article
Show Figures

Figure 1

Figure 1
<p>Analysis of flavonoid (<b>A</b>) and limonoid (<b>B</b>) by HPLC.</p>
Full article ">Figure 2
<p>ABTS and DPPH scavenging abilities and antioxidative indexes of citrus oleoresin. <sup>a</sup> Data presented are in mean ± SD (<span class="html-italic">n</span> = 3), with the different letters indicating significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Oxidation curves obtained for the oleoresin samples extracted from the three citrus varieties as determined by Rancimat.</p>
Full article ">
5004 KiB  
Review
Molecular Mechanisms and Metabolomics of Natural Polyphenols Interfering with Breast Cancer Metastasis
by Yingqian Ci, Jinping Qiao and Mei Han
Molecules 2016, 21(12), 1634; https://doi.org/10.3390/molecules21121634 - 17 Dec 2016
Cited by 48 | Viewed by 10755
Abstract
Metastatic cancers are the main cause of cancer-related death. In breast primary cancer, the five-year survival rate is close to 100%; however, for metastatic breast cancer, that rate drops to a mere 25%, due in part to the paucity of effective therapeutic options [...] Read more.
Metastatic cancers are the main cause of cancer-related death. In breast primary cancer, the five-year survival rate is close to 100%; however, for metastatic breast cancer, that rate drops to a mere 25%, due in part to the paucity of effective therapeutic options for treating metastases. Several in vitro and in vivo studies have indicated that consumption of natural polyphenols significantly reduces the risk of cancer metastasis. Therefore, this review summarizes the research findings involving the molecular mechanisms and metabolomics of natural polyphenols and how they may be blocking breast cancer metastasis. Most natural polyphenols are thought to impair breast cancer metastasis through downregulation of MMPs expression, interference with the VEGF signaling pathway, modulation of EMT regulator, inhibition of NF-κB and mTOR expression, and other related mechanisms. Intake of natural polyphenols has been shown to impact endogenous metabolites and complex biological metabolic pathways in vivo. Breast cancer metastasis is a complicated process in which each step is modulated by a complex network of signaling pathways. We hope that by detailing the reported interactions between breast cancer metastasis and natural polyphenols, more attention will be directed to these promising candidates as effective adjunct therapies against metastatic breast cancer in the clinic. Full article
(This article belongs to the Special Issue Catechins and Human Health: Current State of the Science)
Show Figures

Figure 1

Figure 1
<p>Structures of the major catechins and natural polyphenols.</p>
Full article ">Figure 2
<p>(<b>a</b>) Five-year Relative Survival Rates* (%) by Stage at Diagnosis, US, 2004–2010. Local: an invasive malignant tumor confined to primary organ. Regional: a malignant tumor that has extended into surrounding organs or tissues and regional lymph nodes. Distan<b>t</b>: a malignant tumor that has spread to parts of the body remote from the primary cancer, or via the lymphatic system to distant lymph nodes; (<b>b</b>) The difference in relative survival rates between Regional and Distant metastases, and Value (%) = Regional–Distant. Rates* are adjusted for normal life expectancy and are based on cases diagnosed in the SEER 18 areas from 2004 to 2010, all followed through 2011, and the data are from the American Cancer Society, Inc., Surveillance Research, 2015.</p>
Full article ">Figure 3
<p>Simplified summarizes of metastatic cascade of breast cancer and genes involving in the process of metastasis. Cancer-driven events in the metastatic cascade are delineated in time and space in a counter-clockwise beginning with the primary cancer, and then intravasation into the blood circulation, active or passive migration toward the target organ, embedding into a capillary bed, attachment to the endothelium, and extravasation, which leads to infiltration into the underlying tissue, and expansion in the target microenvironment. MMPs, matrix metalloproteinases; ZEB1, zinc finger E-box-binding homeobox 1; SLUG, zinc finger protein SNAI2; MTA3, metastasis-associated protein; MUC1: mucin 1, cell surface-associated; PSA, prostate-specific antigen; EMMPRIN: extracellular matrix metalloproteinase inducer; uPA: urokinase plasminogen activator; uPAR: urokinase plasminogen activator receptor; PAI: plasminogen activator inhibitor; RECK: reversion-inducing cysteine-rich protein with kazal motifs; PN-II: protease nexin-II; alpha1-AT: alpha 1-antitrypsin; EPCAM, epithelial cell adhesion molecule; CK19, Cytokeratin 19; CEA, carcinoembryonic antigen; SAA, serum amyloid A; LOX, protein-lysine 6-oxidase; RAC1, Ras-related C3 botulinum toxin substrate1; cdc42, cell division control protein 42 homolog; ST6GALNAC5, AGPTL4: promoting seeding; promoting colonization: OPN, CXCR4; COX-, CXCL12/CXCR4: proinflammatory molecules and chemokines/receptors; VCAM-1, TNC, OPN: adhesion and extracellular matrix molecules; SRC, NF-κB: intracellular signaling proteins. The data adapted from the study of Bos and Zhou [<a href="#B8-molecules-21-01634" class="html-bibr">8</a>,<a href="#B14-molecules-21-01634" class="html-bibr">14</a>].</p>
Full article ">Figure 4
<p>Model for the molecular metchanisms of natural polyphenols effects on metastasis. (<b>A</b>) General schematic representation of signalling pathway that regulate MMP-2 and MMP-9 expression, VEGF gene and NF-κB; (<b>B</b>) The proteins that promote cell-cell contact and mesenchymal markers during EMT.</p>
Full article ">
907 KiB  
Article
Safe Synthesis of Alkylhydroxy and Alkylamino Nitramines
by Simen Antonsen, Marius Aursnes, Harrison Gallantree-Smith, Christian Dye and Yngve Stenstrøm
Molecules 2016, 21(12), 1738; https://doi.org/10.3390/molecules21121738 - 16 Dec 2016
Cited by 8 | Viewed by 6039
Abstract
Three different protocols for the syntheses of hydroxyalkylnitramines are presented and compared. Safety issues regarding the synthesis of nitramines are also discussed. Full article
(This article belongs to the Section Green Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Structure of carbamates and cyclic urea derivatives.</p>
Full article ">Scheme 1
<p>Possible synthesis of 2-hydroxyethylnitramine [<a href="#B20-molecules-21-01738" class="html-bibr">20</a>].</p>
Full article ">Scheme 2
<p>Attempted synthesis of 2-hydroxyethylnitramine.</p>
Full article ">Scheme 3
<p>Synthesis of 2-hydroxyethylnitramine.</p>
Full article ">Scheme 4
<p>Synthesis of 1-hydroxy-2-methylpropan-2-ylnitramine.</p>
Full article ">
3139 KiB  
Article
Synthesis and Structural Investigation of New Bio-Relevant Complexes of Lanthanides with 5-Hydroxyflavone: DNA Binding and Protein Interaction Studies
by Alexandra-Cristina Munteanu, Mihaela Badea, Rodica Olar, Luigi Silvestro, Constanţa Dulea, Constantin-Daniel Negut and Valentina Uivarosi
Molecules 2016, 21(12), 1737; https://doi.org/10.3390/molecules21121737 - 16 Dec 2016
Cited by 21 | Viewed by 6652
Abstract
In the present work, we attempted to develop new metal coordination complexes of the natural flavonoid 5-hydroxyflavone with Sm(III), Eu(III), Gd(III), Tb(III). The resultant hydroxo complexes have been characterized by a variety of spectroscopic techniques, including fluorescence, FT-IR, UV-Vis, EPR and mass spectral [...] Read more.
In the present work, we attempted to develop new metal coordination complexes of the natural flavonoid 5-hydroxyflavone with Sm(III), Eu(III), Gd(III), Tb(III). The resultant hydroxo complexes have been characterized by a variety of spectroscopic techniques, including fluorescence, FT-IR, UV-Vis, EPR and mass spectral studies. The general chemical formula of the complexes is [Ln(C15H9O3)3(OH)2(H2O)xnH2O, where Ln is the lanthanide cation and x = 0 for Sm(III), x = 1 for Eu(III), Gd(III), Tb(III) and n = 0 for Sm(III), Gd(III), Tb(III), n = 1 for Eu(III), respectively. The proposed structures of the complexes were optimized by DFT calculations. Theoretical calculations and experimental determinations sustain the proposed structures of the hydroxo complexes, with two molecules of 5-hydroxyflavone acting as monoanionic bidentate chelate ligands. The interaction of the complexes with calf thymus DNA has been explored by fluorescence titration and UV-Vis absorption binding studies, and revealed that the synthesized complexes interact with DNA with binding constants (Kb) ~ 104. Human serum albumin (HSA) and transferrin (Tf) binding studies have also been performed by fluorescence titration techniques (fluorescence quenching studies, synchronous fluorescence spectra). The apparent association constants (Ka) and thermodynamic parameters have been calculated from the fluorescence quenching experiment at 299 K, 308 K, and 318 K. The quenching curves indicate that the complexes bind to HSA with smaller affinity than the ligand, but to Tf with higher binding affinities than the ligand. Full article
(This article belongs to the Section Organometallic Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Primuletin (5-hydroxyflavone).</p>
Full article ">Figure 2
<p>Electronic spectra of the ligand and the complexes (recorded on solid probes).</p>
Full article ">Figure 3
<p>EPR spectrum of <b>3</b> (powder) recorded at room temperature.</p>
Full article ">Figure 4
<p>The optimised structure of the electronic ground state of 5-hydroxyflavone at the B3LYP level of theory (6-31G(d) basis).</p>
Full article ">Figure 5
<p>The optimised structure of the electronic ground state of complexes (<b>1</b>)–(<b>4</b>) at the uB3LYP level of theory (6-31G(d) basis set for C, H atoms; 6-31G+(d,p) for O atoms; MWB28 for lanthanide atoms).</p>
Full article ">Figure 6
<p>Absorption spectra of complex <b>2</b> in the absence and presence of increasing amounts of DNA, respectively; [complex] = 15 μM; [DNA] = 0; 5; 10; 15; 25; 30 μM. The arrow shows the absorption changes on increasing DNA concentration.</p>
Full article ">Figure 7
<p>Absorption spectra of DNA in the absence and presence of increasing amounts of 5-HOF and complex (<b>2</b>). [DNA] = 15 μM; [compound] = 0; 5; 10; 15; 20; 25; 30 μM. Insert figures represent the plots of A<sub>0</sub>/(A − A<sub>0</sub>) vs. 1/[Q]. The arrows show the absorption changes on increasing concentration of the tested compound.</p>
Full article ">Figure 8
<p>Fluorescence spectra of the binding of ethidium bromide (EB) to DNA in the absence (red line) and in the presence (black lines) of increasing amounts of the ligand and complex (<b>2</b>) λex = 500 nm, [EB] = 2 μM, [DNA] = 10 μM, [compound] = 10, 15, 20, 25, 30 μM. Arrows indicate the changes in fluorescence intensities upon increasing the amounts of the tested compound.</p>
Full article ">Figure 9
<p>Fluorescence synchronous spectra of 5-HOF and complex (<b>2</b>) at Δλ = 15 nm (<b>left</b>) and 60 nm (<b>right</b>). [Tf] = 10 µM, pH = 7.4; [tested compound] = 0; 5; 7.5; 10; 12.5; 15; 17.5; 20 µM. Arrows indicate the changes in fluorescence intensities upon increasing the amounts of the tested compound.</p>
Full article ">Scheme 1
<p>The reaction scheme for the synthesis of complexes, where MCl<sub>3</sub> = the lanthanide salt, EtOH = ethanol, TEA = triethylamine.</p>
Full article ">
169 KiB  
Editorial
Special Issue: “Molecules against Alzheimer”
by Michael Decker and Diego Muñoz-Torrero
Molecules 2016, 21(12), 1736; https://doi.org/10.3390/molecules21121736 - 16 Dec 2016
Cited by 3 | Viewed by 6384
Abstract
This Special Issue, entitled “Molecules against Alzheimer”, gathers a number of original articles, short communications, and review articles on recent research efforts toward the development of novel drug candidates, diagnostic agents and therapeutic approaches for Alzheimer’s disease (AD), the most prevalent neurodegenerative disorder [...] Read more.
This Special Issue, entitled “Molecules against Alzheimer”, gathers a number of original articles, short communications, and review articles on recent research efforts toward the development of novel drug candidates, diagnostic agents and therapeutic approaches for Alzheimer’s disease (AD), the most prevalent neurodegenerative disorder and a leading cause of death worldwide. This Special Issue contains many interesting examples describing the design, synthesis, and pharmacological profiling of novel compounds that hit one or several key biological targets, such as cholinesterases, β-amyloid formation or aggregation, monoamine oxidase B, oxidative stress, biometal dyshomeostasis, mitochondrial dysfunction, serotonin and/or melatonin systems, the Wnt/β-catenin pathway, sigma receptors, nicotinamide phosphoribosyltransferase, or nuclear erythroid 2-related factor. The development of novel AD diagnostic agents based on tau protein imaging and the use of lithium or intranasal insulin for the prevention or the symptomatic treatment of AD is also covered in some articles of the Special Issue. Full article
(This article belongs to the Special Issue Molecules against Alzheimer)
222 KiB  
Review
The Health Benefiting Mechanisms of Virgin Olive Oil Phenolic Compounds
by Lisa Parkinson and Sara Cicerale
Molecules 2016, 21(12), 1734; https://doi.org/10.3390/molecules21121734 - 16 Dec 2016
Cited by 151 | Viewed by 14332
Abstract
Virgin olive oil (VOO) is credited as being one of the many healthful components associated with the Mediterranean diet. Mediterranean populations experience reduced incidence of chronic inflammatory disease states and VOO is readily consumed as part of an everyday Mediterranean dietary pattern. VOO [...] Read more.
Virgin olive oil (VOO) is credited as being one of the many healthful components associated with the Mediterranean diet. Mediterranean populations experience reduced incidence of chronic inflammatory disease states and VOO is readily consumed as part of an everyday Mediterranean dietary pattern. VOO is rich in phenolic compounds and the health promoting benefits of these phenolics are now established. Recent studies have highlighted the biological properties of VOO phenolic compounds elucidating their anti-inflammatory activities. This paper will review current knowledge on the anti-inflammatory and nutrigenomic, chemoprotective and anti-atherosclerotic activities of VOO phenolics. In addition the concentration, metabolism and bioavailability of specific phenolic compounds will be discussed. The evidence presented in the review concludes that oleurepein, hydroxytyrosol and oleocanthal have potent pharmacological activities in vitro and in vivo; however, intervention studies with biologically relevant concentrations of these phenolic compounds are required. Full article
1398 KiB  
Article
Validation and Application of an Ultra High-Performance Liquid Chromatography Tandem Mass Spectrometry Method for Yuanhuacine Determination in Rat Plasma after Pulmonary Administration: Pharmacokinetic Evaluation of a New Drug Delivery System
by Man Li, Xiao Liu, Hao Cai, Zhichun Shen, Liu Xu, Weidong Li, Li Wu, Jinao Duan and Zhipeng Chen
Molecules 2016, 21(12), 1733; https://doi.org/10.3390/molecules21121733 - 16 Dec 2016
Cited by 3 | Viewed by 4508
Abstract
Yuanhuacine was found to have significant inhibitory activity against A-549 human lung cancer cells. However, there would be serious adverse toxicity effects after systemic administration of yuanhuacine, such as by oral and intravenous ways. In order to achieve better curative effect and to [...] Read more.
Yuanhuacine was found to have significant inhibitory activity against A-549 human lung cancer cells. However, there would be serious adverse toxicity effects after systemic administration of yuanhuacine, such as by oral and intravenous ways. In order to achieve better curative effect and to alleviate the adverse toxicity effects, we tried to deliver yuanhuacine directly into the lungs. Ultra high-performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) was used to detect the analyte and IS. After extraction (ether:dichloromethane = 8:1), the analyte and IS were separated on a Waters BEH-C18 column (100 mm × 2.1 mm, 1.7 μm) under a 5 min gradient elution using a mixture of acetonitrile and 0.1% formic acid aqueous solution as mobile phase at a flow rate of 0.3 mL/min. ESI positive mode was chosen for detection. The method was fully validated for its selectivity, accuracy, precision, stability, matrix effect, and extraction recovery. This new method for yuanhuacine concentration determination in rat plasma was reliable and could be applied for its preclinical and clinical monitoring purpose. Full article
(This article belongs to the Section Medicinal Chemistry)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Representative MRM chromatograms for yuanhuacine and IS detection in plasma: (<b>A</b>) blank plasma; (<b>B</b>) blank plasma spiked with standard solutions in LLOQ; (<b>C</b>) plasma sample obtained 0.5 h after intravenous administration of yuanhuacine; (<b>D</b>) plasma sample obtained 0.5 h after pulmonary administration of yuanhuacine.</p>
Full article ">Figure 2
<p>Mean plasma concentration-time curves of yuanhuacine after intravenous (<b>A</b>) and pulmonary (<b>B</b>) administration. The results revealed that the effects of yuanhuacine through pulmonary administration compared to intravenous injection could last for a longer time.</p>
Full article ">Figure 3
<p>Chemical structures of yuanhuacine (<b>A</b>) and IS (<b>B</b>).</p>
Full article ">Figure 4
<p>Mass spectra for IS (<b>A</b>) and yuanhuacine (<b>B</b>) detection.</p>
Full article ">Figure 5
<p>The schematic diagram of the pulmonary drug delivery device.</p>
Full article ">
Previous Issue
Next Issue
Back to TopTop